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ABSTRACT 
Jessica K. Pepper: Electronic Cigarettes: Diffusion of a Controversial Innovation 
(Under the direction of Noel T. Brewer) 
 
Introduction: Electronic cigarettes (e-cigarettes) are battery-powered nicotine 
delivery systems that have become increasingly popular in the U.S. and have the potential to 
serve as a harm reduction tool for adult smokers. We sought to understand the diffusion of e-
cigarettes into the U.S. marketplace. 
Methods: A U.S. national sample of 17,522 adults (≥18 years old) completed an 
online survey in March 2013 assessing their awareness of and sources of information about 
e-cigarettes. As part of the same study, smokers (n=6,607) responded to questions about 
perceived health risks related to tobacco products, and smokers who had never tried e-
cigarettes (n=3,253) participated in a between-subjects experiment investigating their 
responses to e-cigarette advertisements. 
Results: Most respondents (86%) had heard of e-cigarettes. The most commonly 
reported sources of information were another person, ads on television, and seeing e-
cigarettes being sold. Smokers believed that e-cigarettes were less likely to cause lung 
cancer, oral cancer, and heart disease than cigarettes, traditional smokeless tobacco, snus, and 
dissolvable tobacco. Ads that emphasized the differences between e-cigarettes and regular 
cigarettes or showed an image of a person using an e-cigarette created the greatest interest 
among smokers in trying the product. 
iv 
Conclusions: The positive reaction to e-cigarettes over other non-cigarette tobacco 
products may be, in part, because e-cigarettes embody more of the desirable features of an 
innovation (relative advantage, compatibility, trialability, and observability). Future research 
should concentrate on understanding the impact of risk beliefs on trajectories of use, 
determining efficient ways to deliver appropriate information about e-cigarettes to the public, 
and examining the effects of changes in the e-cigarette industry (e.g., the entry of 
multinational tobacco corporations into the marketplace and the development of new styles 
of e-cigarettes). 
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CHAPTER 1: ELECTRONIC NICOTINE DELIVERY SYSTEM (ELECTRONIC 
CIGARETTE) AWARENESS, USE, REACTIONS, AND BELIEFS: A SYSTEMATIC 
REVIEW* 
Introduction 
Electronic nicotine delivery systems (ENDS), also called e-cigarettes or electronic 
cigarettes, are battery-operated devices that contain an inhalation-activated mechanism that 
heats a cartridge, producing vapor that the user, sometimes called a “vaper,” inhales. Liquid 
in the refillable cartridges typically has nicotine and humectants, although non-nicotine 
cartridges and disposable models are available. Notably, ENDS do not rely on combustion, 
meaning that users do not expose themselves or others to many of the harmful tobacco smoke 
constituents and particles produced by regular cigarettes.1 ENDS are controversial: safety 
information is sparse and inconsistent,2,3 regulation is in flux,4 and public interest is 
increasing rapidly5 despite the lack of research establishing ENDS’ long-term health effects 
or cessation properties for smokers. In addition, public health advocates are concerned that 
ENDS could act as a gateway to future smoking6 or prevent smokers from quitting by 
maintaining their nicotine addiction or deterring them from using existing, effective cessation 
tools.7 The ENDS literature is expanding rapidly, but to date no systematic review has 
summarized the findings across populations or identified gaps in the research. It is important 
to understand not only patterns of ENDS use across populations and time, but also what 
beliefs and reactions drive either use or avoidance of ENDS. This review seeks to improve
                                                     
* Pepper JK, Brewer NT. Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions, 
and beliefs: A systematic review. Tob Control. Published online November 20, 2013.  
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our understanding of who has used ENDS, how they feel about using them, and what both 
users and non-users think about this controversial product. 
Safety of ENDS  
With any nicotine or tobacco product, health and safety are primary public health 
concerns. However, evidence about the safety of ENDS, particularly related to the “e-liquid” 
in the cartridges, is mixed. The U.S. Food & Drug Administration (FDA) analyzed the 
contents of ENDS cartridges2 and found four major tobacco-specific nitrosamines (TSNAs), 
a family of carcinogenic chemicals, but they reported only that these chemical were detected, 
not whether the amounts detected reached harmful levels.8 A study of the effects of 40 
different samples of refill liquids on pulmonary fibroblasts which model adult lung cells3 
found tremendous variability in cytotoxicity even among individual samples from the same 
brand and flavor.  
Experts disagree about the potential harms of propylene glycol, a chemical that serves 
as a humectant in e-liquid.9,10 While theater fog is associated with impaired lung function,11 
no studies have examined the long-term effects of inhaled propylene glycol in humans.7 
Ingestion of or exposure to liquid nicotine from ENDS cartridges may also be unsafe. Many 
of the cartridges and the packets of e-liquid are not childproof,12 and children might be drawn 
to the candy- and fruit-flavored e-liquids.13 If ingested by a child, high doses of nicotine can 
be fatal.13  
Another concern is the lack of quality control standards. Multiple studies have 
detected nicotine in cartridges labeled nicotine-free.2,14,15 Some cartridges leak, are 
incorrectly or ambiguously labeled, or vary in content even though they are labeled as being 
the same brand and flavor.3,12  
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In sum, scientific consensus has yet to emerge about the degree of danger posed by 
ENDS. Making cartridges and e-liquids child-proof and instituting quality control standards 
would help to avoid some safety problems. Whether purposeful exposure, i.e., ongoing use of 
ENDS, has harmful long-term consequences remains an open question.  
Regulation of ENDS 
Approaches to regulation vary widely. For example, Brazil bans the sale, import, and 
advertising of ENDS, while Finland treats ENDS as medicinal products and bans only 
advertising.16 In the U.S., the FDA is expected to propose deeming regulations in fall 2013.4 
In the meantime, some local governments in the U.S. have taken action to prohibit sales to 
minors or otherwise restrict ENDS use.17 Given that ENDS vary widely, ranging from 
disposable models that can cost several dollars but have limited flavor and nicotine options to 
“personal vaporizers” that can cost several hundred dollars but have hundreds of options for 
flavors and a wider variety of nicotine strengths, it will be important for policymakers to 
issue regulations that cover these different models. 
Public Interest in ENDS 
The public has shown tremendous interest in ENDS, and the popular media has 
extensively covered ENDS.18,19 Celebrities have used them in movies and on television.20 
Between January 2008 and February 2010, online searches for information on ENDS 
increased several hundred-fold.5 ENDS are extensively marketed online, promoted in 
YouTube videos, and advertised on Twitter.21,22  
One result of high levels of public interest is that ENDS have quickly become a big 
business.23-25 The current ENDS industry size is estimated to be $500 million in annual sales 
and increasing rapidly (expected to reach $1 billion by the end of 2013).23,24,26 “Big 
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Tobacco” companies entered the market when Lorillard purchased Blu eCigs, a major ENDS 
brand.27 R.J. Reynolds has also introduced their own ENDS line, and Altria (owner of Phillip 
Morris USA) plans to launch MarkTen ENDS in test markets in summer 2013.25  
In sum, ENDS are increasingly popular, although their safety record is not yet 
established and regulation is still in flux. There is a need to understand what the public 
knows and believes about ENDS, as well as who uses ENDS and why. Health behavior 
theories and the empirical literature show that beliefs and attitudes drive risky behavior, 
including health-protective behaviors like vaccination28,29 and cancer screening30,31 and risk-
taking behaviors like tanning32 and unprotected sex,33 so they may also be important 
motivators of ENDS use. This review does not address product safety or biological 
measurements of ENDS as we believe a separate, in-depth review would better address these 
critical questions. Thus, the goal of this review is to synthesize research on use of and beliefs 
about ENDS in order to identify gaps in the literature, inspire future research questions, and 
understand the implications of these findings for public health efforts.  
 
Methods 
Article Searches 
One investigator (JKP) searched PubMed, CINAHL, Web of Science, EMBASE, and 
PsycInfo for articles published between January 1, 2006 (the year that ENDS became 
available in Europe and 1 year before they became available in the U.S.)34 and July 1, 2013. 
Search terms were: “electronic cigarette” OR “electronic cigarettes” OR “e-cigarette” OR “e-
cigarettes” OR “electronic nicotine delivery.” We selected this set of broad search terms as 
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no relevant medical subject heading (MeSH term) existed at the time of this review. We also 
searched the reference sections of included articles.  
Study Selection 
After removing duplicates, both authors reviewed the titles and abstracts (k=244) and 
discarded were conference or dissertation abstracts (k=17) or articles that were not in English 
(k=21) (see Figure 1.1). Thirteen of the non-English articles had English-language abstracts; 
2 of those appeared to be relevant to the review. The additional 8 articles without English-
language abstracts appeared unlikely to contain relevant information based on translations of 
their titles or visual inspection of the article (e.g., they contained no numbers). We also 
excluded articles that were not relevant to ENDS, typically because the search query 
identified articles with the phrase “i.e. cigarettes” (k=24). In a second step, the first author 
reviewed the remaining abstracts and, when necessary, full articles, and conferred with the 
second author where eligibility was unclear. We excluded articles that did not contain 
original data about ENDS, such as commentaries, literature reviews, and information about 
regulation (k=96); were experiments or laboratory studies without descriptions of “natural” 
patterns of use (i.e., usage not instructed by the researcher) or subjective reports from 
participants on relevant dependent variables (k=26); were not peer-reviewed, such as industry 
reports (k=10); or did not include appropriate dependent variables (i.e., they reported data 
about Internet search engines5,35 or pharmacies; k=3).36 We relied on the expanded Campbell 
approach to assess study quality, focusing on factors that bear on internal validity (study 
design) and external validity (sampling).37 We did not use a quality scoring system that 
yields a single score (e.g., the Jadad scale)38 because of the exceptional breadth of 
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methodologies and dependent variables across the studies and because single-score 
approaches combine distinct and important issues. 
Data Abstraction 
The first author coded the remaining articles (k=47) using a standardized data 
abstraction form. The second author or one of two additional coders reviewed each article, 
conferring with the first author in case of disagreements. Coders recorded ENDS awareness, 
“natural” patterns of use (i.e., use outside of a lab setting, including dual use of ENDS with 
other tobacco products), subjective reactions to use (by users only), and beliefs or reasons for 
use (by users or non-users). We define “dual use” as use of both ENDS and other tobacco 
products in the past 30 days. For the last two outcomes, coders also recorded whether the 
measure assessed: the perceived cost of ENDS, including the relative cost of ENDS and 
regular cigarettes (cost); the possibility that ENDS would serve as a gateway to other tobacco 
use (gateway); health, safety, and side effects, including the relative safety of ENDS and 
regular cigarettes (health); quitting or reducing smoking or tobacco use because of ENDS 
(quit); the use of ENDS to avoid restrictions on smoking (restrict); the degree of satisfaction 
with ENDS’ taste, smell, and quality (satisfaction); the extent to which ENDS have the same 
taste, smell, or feeling of use as regular cigarettes (similar); and changes in withdrawal 
symptoms, desire to smoke, and cravings (withdrawal). For example, the statement “ENDS 
helped me quit smoking” would be classified as quit in the category of reactions, while the 
statement “I started using ENDS because I wanted to be healthier” would be classified as 
health in the category of beliefs or reasons.  
We selected these codes because they represented themes that were frequently 
reported by users or were specific public health concerns. For example, we coded for restrict 
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because public health advocates are worried that people will use ENDS in order to bypass 
existing smoking regulations.7,39 Indeed, one ENDS brand highlights this benefit in its name: 
Smoking Everywhere. We also coded for similar because, as touted by ads for the product, 
ENDS can look, feel, or taste like regular cigarettes as a way to appeal to smokers who might 
swap regular cigarettes for electronic ones. We review perceived cost of ENDS as the same 
objective (actual) cost might be prohibitively expensive for one user but negligible for 
another. 
Because of the potential for industry affiliations and funding to influence conclusions 
in tobacco research,40,41 we coded that the study had a financial relationship with the ENDS 
industry if an ENDS manufacturer or distributor funded the study or supplied ENDS or 
cartridges to the researchers.  
 
Results 
Forty-nine studies from 47 articles about ENDS met the inclusion criteria (Table 1.1). 
The number of study participants ranged from 1 to 25,029. Of studies that reported location, 
most were conducted in the United States (k=23) or with participants from multiple countries 
(k=7). Other common locations included Italy (k=5) and the UK (k=4). Twenty-five studies 
used cross-sectional or repeated cross-sectional surveys, 8 were laboratory experiments, 5 
were case reports, 4 were observational, 3 were prospective trials, 2 used qualitative 
interviews, and 2 used focus groups. Fourteen studies used probability sampling. Six studies 
relied on industry support; 7 studies did not report this information. Detailed descriptions of 
study findings appear in Appendix 1. 
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Studies had several important limitations. Nine studies recruited ENDS users in ways 
likely to overrepresent satisfied users (e.g. from online user forums, websites that sell ENDS, 
or ENDS conventions42-50). It would be difficult to generalize to other populations based on 
some studies’ samples (e.g., customers exiting shops in Prague;51 freshman and sophomore 
students recruited from one college lecture class;52 and YouTube videos of ENDS and 
cigarette users22). Thirteen studies did not report the date or location of data collection. 
Finally, although ENDS require some time to learn to use and models vary in quality, at least 
five laboratory studies tested only one model of ENDS or did not provide time for 
participants to learn to use the product.53-57  
Awareness of ENDS 
ENDS awareness is generally high and increasing. In three large national surveys 
with probability sampling, awareness of ENDS among U.S. adults increased from 16% in 
200958 to 32-41% in 201058-60 and 58% in 2011.60 Men were more likely to be aware of 
ENDS than women in 2 of the 3 studies,58,59 and younger respondents were typically more 
likely to be aware of ENDS than older respondents.58-60 In all three studies, African-
American participants were less likely to have heard of ENDS than White participants. 
Current smokers were always more likely to have heard of ENDS than never smokers and 
sometimes more likely than former smokers. For example, in a 2011 U.S. study, 77% of 
current smokers, 65% of former smokers, and 50% of never smokers had heard of ENDS.60 
Studies in other countries found similar patterns of awareness. The International 
Tobacco Control (ITC) Four-Country Survey examined awareness of ENDS among 
probability samples of current and former smokers in 2010-2011 in the U.S., U.K., Canada, 
and Australia. Across the four countries, younger, male, current smokers were more likely to 
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have heard of ENDS than older, female, former smokers.61 Awareness was higher in the U.S. 
(73%) and U.K. (54%), where ENDS can be legally marketed and sold, than in Canada 
(40%) or Australia (20%), where they cannot be sold and may be more difficult to obtain.61 
In a more recent survey of U.K. adults, awareness varied by smoking status; 79% of daily 
smokers compared to 38% of never smokers had heard of ENDS in 2012.62  
Awareness among youth was variable. Only 10% of a probability sample of middle- 
and high-school students surveyed in 2008 in Korea was aware of ENDS.63 In contrast, 86% 
of Polish students (ages 15-24)64 and 70% of Midwestern U.S. young adults (ages 20-28)65 
had ever heard of ENDS in separate probability-based surveys. In the latter, males, current or 
former smokers, and participants with at least one close friend who smokes were more likely 
to be aware of ENDS than their counterparts.65 Two-thirds (67%) of U.S. adolescent boys 
ages 11-19 had heard of ENDS when surveyed in 2011.66 The discrepancy between the low 
rates of youth awareness in Korea and the high rates in Poland and the U.S. may be due to 
regional differences or the dates of data collection. 
In addition to the ITC Four-Country survey, two other studies examined awareness 
only among current and former smokers. More than half (58%) of U.S. smokers were aware 
of ENDS in a large 2010 survey.59 Most (86%) of a convenience sample of adults exiting 
stores in Prague, Czech Republic after having purchased cigarettes had heard of ENDS.51  
Only 3 studies reported sources of awareness. The most common sources were the 
Internet, friends or personal contacts, and advertisements.42,50,63  
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Use of ENDS  
Ever Use  
In large surveys, use of ENDS was low but increasing. Only 1% of U.S. adults 
surveyed in 2009 had tried ENDS.58 Prevalence of use among the general U.S. adult 
population was higher but still minimal (2-3%) when assessed in 2010 in four national 
surveys with probability samples.58-60,67 In all of these studies, more current smokers had 
tried ENDS than former smokers or never smokers.59,60,67 Rates of use in the U.S. continued 
to rise in 2011 (6% overall) with the same gradient pattern by smoking status (1% of never 
smokers, 7% of former smokers, and 21% of current smokers).60 Demographic correlates of 
use varied across studies. When these studies limited their samples to only smokers, ENDS 
use was unrelated to history of quit attempts in 2 studies,58,59 but smokers in one study who 
intended to quit in the next 6 months were more likely to have tried ENDS than smokers with 
no intention to quit.59 
Multiple studies included only current and former smokers in their samples. Across 
the four countries surveyed by ITC, 8% of current and former smokers had ever tried 
ENDS.61 Daily heavy smokers had the highest use, and long term quitters had the lowest use. 
ENDS users were not more likely to have quit smoking since the previous wave of the ITC 
survey than non-users. Twenty-percent of adult U.S. smokers had tried ENDS when surveyed 
as part of a 2011 probability panel.68 Unsuccessful quitters were more likely to have tried 
ENDS than those who had never tried to quit. In another probability panel of U.S. smokers, 
10% of cigarette-only smokers had tried ENDS, but 24% of dual cigar and cigarette users had 
done so.69 Current smokers in the Legacy Longitudinal Smoker Cohort were more likely to 
have tried ENDS than former smokers (6% versus 3% respectively).59 Li and colleagues 
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found that 7% of current smokers and recent quitters in New Zealand in 2011 had ever 
purchased an ENDS (a proxy for use).70 Finally, in the most recent survey of ENDS use in 
2012, 22% of current smokers in the U.K. had ever tried ENDS, compared to 4% of former 
smokers and <1% of never smokers.62 In many of these studies of current and former 
smokers, women61,68 and younger participants59,61,62,68,70 had higher rates of use than never 
smokers, men, and older participants. In some studies, ENDS use was not associated with 
quit attempts59,70 or quit intentions.59,61,68 
In surveys with probability samples, use of ENDS by adolescents and young adults 
varied considerably by region and year, from less than 1% (U.S. male adolescents in the U.S. 
in 2011 and Korean adolescents in 2008)63,66 to 21% (Polish high school and university 
students in 2010-2011).64 In other surveys with probability sampling, 5% of college students 
in North Carolina71 and 7% of young adults in the Midwestern U.S. had tried ENDS.65 In 
general, the higher rate of ENDS use among Polish youth compared to U.S. youth may relate, 
in part, to higher population-wide rates of tobacco use in Poland than in the U.S.72,73 Across 
studies of youth, males,63-65,71 smokers,63-65,71 and those with important others (friends, 
family, or partners) who smoked64,65 were often more likely to have tried ENDS than their 
counterparts. In at least two studies, the relationship between ever use of ENDS and smoking 
status should be interpreted with caution due to the very low prevalence of smoking in the 
sample.63,66 
 Other reported rates of ever use of ENDS are difficult to interpret because of the 
nature of their samples. For example, 85% of a convenience sample of adults surveyed by 
Etter & Bullen had used ENDS, but the majority of their participants were recruited through 
online ENDS forums.44 Among callers to seven tobacco quitlines who responded to a follow-
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up survey (35% response rate), 31% had ever tried ENDS, and users were less likely to have 
quit smoking since their initial call to the quitline than non-users.74 
Current Use 
Adults consistently reported low current use (i.e., in the past 30 days). Around 1% of 
respondents were current ENDS users in three 2010 U.S. national, probability-based 
surveys.58,59,67 As with ever use of ENDS, current smokers were more likely to be current 
ENDS users than either former or never smokers.58,59,62 In surveys limited to current and 
former smokers, rates varied from 3% (across four countries in 2010-2011 ITC survey)61 to 
8% (U.S. in 2011).68 In a convenience sample of callers to tobacco quitlines, 9% of current 
and former smokers reported that they currently used ENDS some days or every day.74 
Youth also reported low current use. Only 1% of young adults in the Midwestern 
U.S.65 and 2% of North Carolina college students71 were current ENDS users in 2010-2011 
and 2009, respectively. Possibly reflecting the overall higher rates of smoking in Poland 
compared to the U.S., a higher percentage of high school and university students (7%) were 
current ENDS users.64 
Dual Use 
In population-based surveys, most current (or past 30 days) smokers were not current 
(or past 30 days) ENDS users. In two 2010 probability samples of U.S. adults, 4%59 and 6%58 
of current smokers had used ENDS in the past 30 days. More than 11% of those who were 
current users of more than one tobacco product (e.g., cigarettes, cigars, snuff, hookah) had 
used ENDS in the past month.58 In another probability sample, 11% of Polish youth and 
young adults who were current smokers had used ENDS in the past 30 days.64 In a large 
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survey with U.K. adults based on an opt-in survey panel, 3% of daily smokers in 2010 and 
7% of daily smokers in 2012 used ENDS.62 
Dual use of ENDS with regular cigarettes was fairly common in convenience 
samples. In surveys with convenience samples of dedicated ENDS users, 12-34% of ENDS 
users were current smokers.42,44,46,47 Of 179 ENDS users, 6% used hookah, snuff, or some 
other non-cigarette tobacco product.47 However, among a sample of people who had bought 
ENDS 6 months earlier, 35% of current ENDS users did not smoke cigarettes, suggesting up 
to 65% dual use.48 Finally, in three prospective trials with convenience samples, dual use of 
ENDS and regular cigarettes appeared to be common, with some of the smokers who reduced 
their consumption of cigarettes continuing to use ENDS at the end of the study.75-77  
Amount and Duration of Use 
Daily use among ENDS users was common43-47,55 in all but two studies.48,74 It is 
difficult to further quantify the amount of use because, unlike regular smoking which can be 
measured by the number of cigarettes smoked, ENDS use has no clear metric. An individual 
does not usually “vape” an entire cartridge of an ENDS in a single sitting. Some studies 
quantified use by estimating puffs per day (range 120-236),42-45 while others reported the 
number of bouts of use per day (median of 20 per day46 or 67% use more than 15 times per 
day).47 Measurements of the number of e-liquid cartridges (range 0-4)75-77 or ml of e-liquid 
used per day (range 3-5 ml)42,55 are difficult to interpret because cartridges leak, vary in 
strength both within and across brands, and require different levels of vacuum to inhale.3,12,78 
Another metric for quantifying use is puff duration. Two studies, one in a laboratory55 and 
one that examined 73 YouTube videos,22 found that ENDS users take longer puffs on ENDS 
than conventional smokers do on regular tobacco cigarettes.  
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Ten studies reported how long participants had been using ENDS.42-47,50,55,74,79 
Estimates varied from less than 1 month of prior use for 62% of callers to state quit lines74 to 
a mean of 13 months of use in a convenience-based survey of experienced ENDS users 
(n=104) conducted in 2011.46 We are not aware of any data about the extent or amount of use 
of disposable ENDS, although 5 studies described the use of modified ENDS (sometimes 
called “mods”) or personal vaporizers that do not mimic the appearance of regular 
cigarettes.42,46,49,50,79  
Subjective Reactions to Using ENDS  
Cost 
ENDS users’ experiences with the cost savings from using ENDS in lieu of regular 
tobacco cigarettes are inconsistent.43,50 In open-ended survey questions, some participants in 
a convenience sample survey of ENDS users (n=81) said that they found ENDS to be less 
expensive than cigarettes (10 comments), while others said they were too expensive (14 
comments).43 Most dedicated ENDS users interviewed at a convention (n=15) found them 
less expensive than cigarettes.50 Finally, among Czech smokers who had tried but stopped 
using ENDS, 13% did so because they found ENDS to be too expensive.51 
Gateway Use 
Among the 179 Polish ENDS users surveyed online in 2009, 25 reported that they 
were non-smokers when they previously began using ENDS. Of those, 20% (n=5) currently 
smoked cigarettes at the time of the survey.47 
Health and Safety 
Many users report positive changes in their health after they begin using the product. 
In surveys, interviews, and case reports, users often describe improved breathing,42,43,50 less 
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coughing,42,43,50 fewer sore throats,43  and improvements in overall health and fitness.43,50,80 
In one case report, switching from cigarettes to ENDS alleviated a patient’s previously 
elevated white blood cell count (neutrophilia).81 
Some users also report experiencing side effects from using ENDS. As of the first 
quarter of 2012, the FDA had received 47 reports about adverse events related to ENDS 
use.82 Of those, they classified 8 as serious adverse events, including pneumonia and chest 
pain, and 39 as minor, including headache and cough. Of the 405 health effects reported by 
users in an online ENDS forum, 326 were negative; the most frequently reported problems 
were in the mouth, throat, respiratory system, and neurological system.83 One case report 
described a patient developing lipid pneumonia,84 and another described a patient 
experiencing heart arrhythmia from using ENDS.85  
In surveys with non-probability samples, laboratory research, and other case reports, 
the majority of reported side effects were minor, including mouth or throat 
irritation/dryness,42-44,53 cough,47,80,86 vertigo,43,53 headache,43,47,53 and nausea.43,53 In three 
prospective trials in which smokers tried ENDS for 6 or 12 months, there were no serious 
adverse events.75-77 Many of the minor side effects experienced at baseline, including 
cough,75-77 mouth and throat irritation,75,77 and headache,76,77 lessened considerably or 
resolved completely by the end of the study period. 
Quitting or Reducing Tobacco Use 
Although successful quitting was generally not associated with ENDS use in large 
surveys,58,61,68,74 in convenience sample surveys, focus groups, case studies, and interviews 
with dedicated ENDS users, they often reported that using the product helped them quit 
smoking42-44,46-50,80,81,86 or significantly reduce tobacco use,42,44,48 often despite being heavy 
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smokers or having failed quit attempts in the past.43,44,46,48-50,80,81,86 Unlike quitting smoking, 
reducing smoking may not represent a positive public health outcome, given that it may 
indicate dual use of ENDS and regular cigarettes.  
Only three longitudinal studies have examined smokers’ use of ENDS to quit 
smoking. Two of the three prospective trials were uncontrolled. In the first, a 12-month trial 
with 14 patients being treated for schizophrenia, 7 of 14 participants reduced their smoking at 
least 50% and 2 others quit smoking entirely.76 In the second, a 6-month prospective trial of 
40 smokers, 13 were lost to follow-up, 13 reduced their cigarette consumption by at least 
50%, and an additional 9 participants quit smoking entirely.75 Another prospective trial 
randomly assigned 300 smokers to use either ENDS with nicotine or ENDS without 
nicotine.77 At the end of the 12-month period, 11% of smokers using ENDS with nicotine 
had quit and 10% reduced their cigarette consumption by at least 50%, while 4% of the non-
nicotine group had quit and 12% had reduced their consumption. More than one-third were 
lost to follow-up. The differences in cessation between groups were not statistically 
significant. The results of these trials should be interpreted with caution given that only one 
randomized participants to conditions (and it did not include a comparison condition with an 
alternative quit aid), and all three relied on convenience samples in a limited geographical 
setting.  
Restrictions on Smoking 
The extent to which smokers use ENDS to avoid smoking restrictions was not clear. 
About one-third (36%) of ENDS users in one survey said that they frequently used ENDS in 
places where smoking was banned.42 In contrast, in another survey of ENDS enthusiasts 
(n=104) recruited from a convention, 90% said they were able to use where smoking was 
17 
banned, although they did not clarify how often they did so.46 In a third survey, a substantial 
number of daily ENDS users from a variety of countries reported using their ENDS at work 
(71%) or in cafes, restaurants, or bars (43%), but it is difficult to interpret these results with 
respect to avoiding smoking restrictions given that restrictions vary by country.44  
Satisfaction  
Satisfaction with ENDS that contained nicotine was moderate in most laboratory 
studies53,56,57,79 and very high in surveys of committed ENDS users.42-44,49,50 Users often 
mentioned taste and flavor. For example, more than 90% of users surveyed by Etter and 
Bullen liked the taste of ENDS.44  Smokers who used ENDS in prospective trials had mixed 
reactions,75,77 as did many smokers interviewed in Prague.51 Finally, in 5 studies, ENDS 
users expressed concerns about the quality of ENDS they used, including leaking cartridges 
or broken components.43,44,50,51,75 Some stopped using ENDS because of problems with the 
devices.44,51 
Similarity to Regular Cigarettes 
Studies showed little agreement about how much users of ENDS thought they look, 
feel, or taste like cigarettes, as well as whether similarity to cigarettes was a benefit or a 
drawback. In small focus groups with former smokers (n=11), users mentioned that they not 
only liked how using ENDS mimicked the feel of smoking cigarettes, but also that they 
swapped regular cigarettes for ENDS as part of the same daily routines (e.g., used after a 
meal).49 The similarity between the products also made it easier to switch from one to the 
other. Other ENDS users recruited at a convention (n=15) noted that their desire for ENDS to 
mimic regular cigarettes had changed over time; although they began using ENDS that 
looked and felt like cigarettes, most transitioned to using personal vaporizers that did not 
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look like cigarettes.50 In a large convenience sample survey, over half of participants said 
they used ENDS “in a similar manner” as cigarettes.42 A small number of users stopped using 
ENDS because they did not have the same flavor,43 but others preferred the flavor of ENDS 
to regular cigarettes.46 During bouts of use of ENDS as part of lab studies (n=20 and n=32), 
participants’ ratings of “mild as own brand”56,57 and “taste like own brand”57 increased as 
they continued to use the product. In direct comparisons, about two-thirds of users in separate 
convenience sample surveys rated ENDS as equally or more satisfying than cigarettes.42,47 
Withdrawal Symptoms, Desire to Smoke, and Cravings 
ENDS typically provided some relief of smokers’ nicotine cravings and withdrawal 
symptoms. In 6 lab studies, participants who had been tobacco abstinent for 2-12 hours 
reported that using nicotine-containing ENDS reduced their desire to smoke or cravings 
during their in-laboratory use session,53,56,57,79,87,88 although this was not true in 1 study.54 In 
some cases, this reduction was shown to be greater for nicotine-containing ENDS than for 
non-nicotine ENDS53,87,88 or for just holding unlit regular cigarettes or ENDS.56,88 
Interestingly, this reduction in desire to smoke or lessening of cravings occurred even in 
some cases where objectively measured nicotine uptake was low or modest.53,56 Evidence for 
the alleviation of specific withdrawal symptoms in these lab studies was 
inconsistent.53,56,57,79,87,88  
Dedicated ENDS users frequently reported that using ENDS successfully reduced 
their cravings to smoke and some withdrawal symptoms.42-44,46,49,50 For example, experienced 
“vapers” interviewed at the Midwest Vapefest “routinely described relief of nicotine cravings 
within 5 minutes of vaping” and said they could comfortably go long periods of time 
between bouts of use without experiencing withdrawal symptoms.50  However, in a large 
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online survey with current and former users, 33% of users said they stopped using because 
ENDS did not reduce their cravings.44 Finally, in the three prospective trials in Italy that 
followed smokers who began using ENDS for 6-12 months, participants experienced few or 
no withdrawal symptoms.75-77 
Beliefs about and Reasons for Using ENDS 
Cost 
ENDS users’ beliefs about the cost savings from using ENDS in lieu of regular 
tobacco cigarettes are inconsistent. In multiple convenience sample surveys from the U.S. 
and other countries, a small percent of users said they first tried or used ENDS for cost 
savings,42,43,47,74 although a much higher percent reported this reason in another convenience 
sample survey.44 More than half (53%) of U.K. smokers, including a mix of users and non-
users, believed that ENDS might be too expensive.62  
Gateway Use  
One study documented beliefs about ENDS as gateways to use of tobacco products. 
Young adult smokers and non-smokers in focus groups in Minnesota, U.S. believed that 
ENDS and other novel tobacco products, including snus and dissolvable tobacco, might 
appeal to non-smokers who have “always wanted to know the feeling of a cigarette.”89 They 
felt that these products could lead non-smokers to become smokers. 
Health and Safety 
Many users believe that ENDS are healthier than regular cigarettes for themselves42-
44,46,47,49,50 or for others,46 and they use ENDS for this reason. For example, of 179 Polish 
adult ENDS users in a convenience sample, 82% believed that ENDS were less dangerous 
than cigarettes, and an additional 15% believed that ENDS were “absolutely safe.”47 
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Typically only a handful of users are concerned about the potential negative health effects or 
toxicity of ENDS.43,44 
Respondents in surveys that include non-users generally indicate slightly less 
confidence in the healthfulness of ENDS. In three probability sample surveys of adult current 
and former smokers, 70-85% of those who were aware of ENDS believed they were less 
harmful than regular cigarettes.59,61 In a non-probability survey of adult smokers in the U.K., 
71% held this belief, although 21% still felt that ENDS might not be safe enough.62 Only 
one-third of adult New Zealand smokers believed that ENDS were less harmful than regular 
cigarettes.70  
In multiple studies of students and young adults, 23-55% believed that ENDS were 
safer than regular cigarettes.64,65,71 In focus groups, young adults who had never tried ENDS 
expressed mixed beliefs about whether ENDS were equivalent to or less harmful than regular 
cigarettes.89  
Examining Twitter accounts related to smoking cessation, Prochaska and colleagues 
also found a range of beliefs about the healthfulness of ENDS, including tweets with health 
warnings as well as tweets touting health benefits.90  
Quitting or Reducing Tobacco Use 
The majority of ENDS users believe that ENDS can help people quit or reduce 
smoking, and they often use ENDS themselves for this reason.42-44,46,47,49,61,62,74,80 Two 
surveys with probability sampling described beliefs about the cessation properties of ENDS. 
Among Midwestern young adults (ages 20-28), almost half (45%) of those who had heard of 
ENDS agreed that they can help people quit smoking.65 One-third of New Zealand smokers 
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believed that ENDS could help smokers quit, and 58% said they would be willing to try 
ENDS for that reason.70  
In two studies in which researchers provided smokers with ENDS (both n=40), those 
smokers later said that they would recommend ENDS to friends or family who wished to quit 
smoking.53,75 Some commercial and personal Twitter accounts also promoted ENDS as a quit 
tool.90 Finally, in focus groups of young adult non-users (n=66), participants expressed 
differing opinions about whether ENDS could be used as a cessation device, and some 
spontaneously recounted anecdotes about people they knew who quit smoking using 
ENDS.89  
Restrictions on Smoking 
ENDS users have conflicting beliefs about using ENDS to avoid smoking restrictions. 
In some surveys, only a small percent of users describe this as a motivation.42,43,47,74 
However, in other surveys, more than 40% of respondents said they used ENDS for this 
reason.46,61,62 
In small focus groups, non-users noted that an advantage of ENDS and other novel 
tobacco products (snus, dissolvable tobacco) is the ability to get around smoking bans and 
use them in places where one cannot smoke.89  
Satisfaction 
Some vapers use for the pleasure of the experience.43 Smokers who have not tried 
ENDS had mixed opinions about their potential satisfaction. About one-third believed that 
ENDS might taste unpleasant.62 
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Similarity to Regular Cigarettes 
Some smokers and users liked that ENDS resembled or felt like regular cigarettes, 
while others considered this a drawback.42,43,62,74 Certain elements of the vaping and smoking 
experiences were clearly different. Because ENDS are more complex than cigarettes, 
interviewed users (n=15) noted that, unlike cigarettes, they required a learning curve to use 
properly.50 In focus groups, some young adult smokers mentioned that the social experience 
of smoking might not be replicated with ENDS.89  
Withdrawal Symptoms, Desire to Smoke, and Cravings 
Beliefs about the addictive properties of ENDS vary. About one-quarter of 
Midwestern young adults, most of whom were non-users, believed that ENDS are less 
addictive than regular cigarettes.65 In contrast, in an Internet-based survey of a convenience 
sample of Polish ENDS users, 60% believed that ENDS were less addictive than regular 
cigarettes, and an additional 7% believed that ENDS were not addictive at all.47 However, 
more than half believed they were addicted to ENDS.  
Very few (8%) ever users in another online survey said they were afraid of becoming 
addicted to ENDS, although 4% of the sample stated that they used ENDS because they were 
unable to stop using them.44 More than half (60%) of U.K. smokers, only some of whom had 
used ENDS, believed that ENDS might satisfy the desire to smoke.62 Indeed, some vapers 
used ENDS to relieve their cravings or alleviate their withdrawal symptoms.43,44,46,50,74 
Other Beliefs 
Three other important themes emerged in the literature. First, concerns about personal 
appearance (e.g., preventing yellow teeth) or odor (e.g., clothes not smelling like smoke) 
sometimes motivated interest in or use of ENDS.43,44,47,49,50,62,75,89 Second, ENDS users felt a 
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sense of camaraderie with one another; they gathered at vaping conventions46,50 and in online 
forums where they shared information, recommendations, and personal experiences.43,49,50 
However, a small minority of ENDS users were concerned about the social acceptability of 
ENDS use and felt embarrassed about using the product.42,51 University students, few of 
whom had tried ENDS, viewed ENDS use as more socially acceptable than smoking.52 Third, 
some ENDS enthusiasts were concerned that the product will be banned.43,44,50 We did not 
find any arguments by users that ENDS should be specifically exempted from smoke-free 
indoor air laws. 
 
Conclusions 
As the public health community settles an internal debate over the safety and 
cessation properties of ENDS, interest and use by the public are increasing rapidly. 
Consistently across the literature, current and former smokers were more likely to be aware 
of and use ENDS than non-smokers, although quit intentions and attempts were often not 
associated with ENDS use. In surveys and interviews with dedicated ENDS users, users were 
generally satisfied with the product and believed it was healthier than regular cigarettes. 
Current and former smokers not only believed that ENDS could help them quit smoking, but 
a significant proportion reported that ENDS already helped them reduce the amount they 
smoke or quit entirely. Dedicated ENDS users who are or were smokers often commented 
that ENDS alleviate their cravings to smoke, and they felt healthier because of using ENDS. 
Some evidence suggested that smokers use ENDS in order to avoid smoking restrictions, but 
no longitudinal studies have evaluated whether ENDS serve as a gateway to future tobacco 
use. In lab-based studies, smokers often reported that ENDS reduced their desire to smoke 
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and alleviated some withdrawal symptoms, although they experienced minor side effects. In 
prospective trials testing ENDS as a potential quit aid, a moderate number of smokers were 
able to quit, but many appeared to engage in dual use of ENDS and regular cigarettes. 
Some of the reviewed studies received either funding from ENDS companies or used 
ENDS that these companies donated. Prior systematic reviews have found that financial 
relationships may influence study findings. For example, nearly all studies funded by the 
tobacco industry found a relationship between smoke-free restaurant and bar laws and 
reduced sales or employment in the hospitality industry; none of the non-industry supported 
studies found this association.40 Although we detected no apparent pattern of results 
associated with ENDS industry funding, it remains important to be aware of possible 
conflicts of interest when interpreting these findings. 
The literature on ENDS described in this review suggests several important questions 
that future research should address. First, future research should identify effective messages 
for discouraging ENDS use among vulnerable populations, given the beliefs and attitudes 
identified in our review. Two specific vulnerable populations are non-smokers who could 
begin smoking as a result of developing nicotine addiction from ENDS use and smokers who 
use ENDS only as a bridge to their next cigarette. If we better understand why ENDS may be 
attractive to some vulnerable populations (e.g., teenagers think ENDS are fashionable),89 we 
can craft and deliver effective messages that deter use. 
Another question for future research is how well perceived health risks of using 
ENDS correspond to objective risks, and whether beliefs about these risks change as 
additional safety data become available. Future safety studies will hopefully clarify some of 
the conflicting findings of past studies.2,3,9 Current ENDS users who are former smokers 
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frequently state that they use ENDS because they are healthier than regular cigarettes. If 
future safety studies find evidence of long-term harms, will these ENDS users stop using? If 
not, can we improve how we communicate safety information? Designing appropriate 
warning labels on ENDS packages could be an important first step.  
A third important research question is whether ENDS users’ self-reports of successful 
smoking cessation match evidence from the currently ongoing randomized controlled trials 
(RCTs) evaluating the efficacy of ENDS as a smoking cessation tool. Caponnetto and 
colleagues conducted a randomized controlled trial, but it did not include an arm testing an 
alternative to ENDS (i.e., nicotine replacement therapies (NRTs) or other proven smoking 
cessation methods).77 Bullen and colleagues recently described the protocol for their study in 
which adult smokers who want to quit are randomly assigned to use ENDS with 16 mg 
nicotine cartridges, 21 mg nicotine patches, or placebo (ENDS with 0 mg nicotine).91 The 
primary outcome is the proportion of participants who maintain smoking abstinence 6 
months after the start of the study, but investigators will also assess reductions in smoking, 
safety of the ENDS and patches, and perceptions of the products. This RCT and other similar 
studies are critical to understanding whether, as users have reported, ENDS can serve as 
harm reduction tools.  
Finally, it will be important to understand how users of the various kinds of ENDS 
differ. ENDS are available in many different varieties. For example, there are disposable 
ENDS, often available at gas stations for only a few dollars, and more expensive refillable 
models that require an initial investment for a starter kit. Some ENDS mimic the appearance 
of regular cigarettes, while some modified ENDS do not resemble cigarettes. Understanding 
whether and why different types of ENDS appeal to different populations could assist efforts 
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to regulate these products. For example, if young people who have not already initiated 
tobacco use prefer inexpensive, readily available disposable models, restricting the sale of 
these models would be a key public health priority. 
Several additional research questions, beyond the scope of the material covered in 
this review, will also be important to answer. One key question is whether ENDS are safe to 
use. Observing adverse events in RCTs, such as the one described by Bullen and colleagues, 
will help to determine this. What is the best way to measure ENDS use (e.g., number of puffs 
versus number of e-liquid cartridges used) so that findings can be compared across studies? 
Do ENDS act as gateway devices, causing individuals who would not otherwise use tobacco 
to initiate use? More than 10% of college students who reported using ENDS had never 
smoked a conventional cigarette,71 and we do not yet know whether those young people will 
start smoking as a result of their experience with ENDS. Prospective cohort studies, 
particularly with adolescents and young adults, are necessary to track patterns of use of 
ENDS and other tobacco products. Other important questions posed by a recent Cancer 
Research U.K. report include how will future regulation impact quit attempts using ENDS; 
do ENDS “re-normalize” smoking; and are ENDS undermining the use of other NRTs in 
smoking cessation attempts?16 
Limitations to this systematic review include that, because the quality of the studies 
included in this review varies tremendously, readers should interpret the findings with care. 
In addition, as we reviewed only articles written in English and indexed electronically or 
cited in papers we reviewed, the review may have missed some relevant articles. While we 
provide an overview of findings across the literature, we did not conduct a meta-analysis to 
provide a quantitative synthesis due to the small number of studies and variability in their 
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designs and measures. Also, the codes we developed may not have included all relevant areas 
and some findings may have overlapped across codes. Finally, because this literature is 
young and evolving quickly, the conclusions of this review may not capture all of these 
changes.  
In sum, concerns about ENDS include their safety, the lack of regulation, the 
possibility of gateway use, and the potential for dual use or avoidance of existing smoking 
restrictions. However, harm reduction advocates note that ENDS may be less harmful—and 
are highly unlikely to be more harmful—to smokers than regular cigarettes which are a 
proven cause of morbidity and mortality.8,92 Thus the concerns about ENDS must be 
balanced with the possibility that ENDS could prove to be a valuable harm reduction tool for 
addicted adult smokers, provided they do not encourage dual use or prevent other cessation 
efforts. Furthermore, as we learn more about the safety of ENDS and their efficacy as a quit 
tool, we will hopefully be able to design better tobacco control and cessation programs in the 
future.  
 
 
 Table 1.1. Characteristics of Studies Included in Review 
 
1st Author 
(year) 
n Country 
(State) 
Population Probability 
Sampling 
of Cases 
Data 
collection 
date 
Study 
Design 
Financial 
Relationshi
p 
Key Limitations 
Adkison 
(2013)61 
5,939 US, UK, 
Canada, 
Australia 
≥18 years, T Yes Jul 2010-
Jun 2011 
Survey No Survey wave response rate not 
reported. 
Barbeau 
(2103)49 
11 US (MA) 18-64 years, 
M, ENDS 
users 
No Feb 2010 Focus 
groups 
NR Recruited from ENDS user forums 
and advocacy groups.  
Bullen 
(2010)53 
40 New 
Zealand 
18-70 years, 
T, ENDS 
naïve  
No Jan-Feb 
2008 
Exper Yes <1 day of exposure. Did not 
provide time for participants to 
become familiar with using ENDS. 
Did not achieve desired (power) 
sample size. Some participants still 
smoked on days assigned to 
ENDS. Only tested 1 model of 
ENDS. 
Caponnetto 
(2011)86 
2 Italy 50-51 years, 
T, ENDS 
users 
No Jan 2010 Case 
report 
No Only 2 participants.  
Caponnetto 
(2011)80 
3 Italy 38-65 years, 
T, ENDS 
users 
No NR Case 
report 
No Only 3 participants.  
Caponnetto 
(2013)76 
14 Italy Mean 45 
years (SD 
13), T  
No NR Prosp 
trial 
Yes Uncontrolled trial of people with 
schizophrenia. 
Caponnetto 
(2013)77 
300 Italy Mean 44 
years (SD 
13), T 
No 2010-2011 Prosp 
trial 
Yes Control group tested non-nicotine 
ENDS, not alternative cessation 
products. Recruitment ads 
described ENDS as healthier than 
cigarettes. 39% lost to follow up. 
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Chen 
(2013)82 
47 
adverse 
event 
reports  
US N/A No 2008 – 
2012 
Observ No Adverse events may not be caused 
by ENDS. 
Cho 
(2011)63 
4,341 Korea Mean 14 
years (SD 1) 
in middle 
schools, 
mean 17 
years (SD 1) 
in high 
schools, M 
Yesa 2008 Survey No Regional sample. Did not ask 
about current use of ENDS so 
could not assess dual use. 
Choi 
(2012)89 
66 US (MN) 18-26 years, 
M 
No Jul-Dec 
2010 
Focus 
groups 
No Small group size in some focus 
groups. Did not differentiate 
comments from smokers vs. non-
smokers or whether certain 
comments were relevant to ENDS 
versus other tobacco products. 
Choi 
(2013)65 
2,624 US (MN, 
SD, ND, 
MI, KS) 
20-28 years, 
M 
Mixedb Oct 2010-
Mar 2011 
Survey No Regional sample. Mix of 
probability and non-probability 
sampling. 
Dawkins 
(2012)88 
86 United 
Kingdom 
18-52 years, 
T, ENDS 
naïve  
No NR Exper Yes Did not include a comparison 
condition in which participants 
smoked cigarettes. Participants 
were only 1-2 hours abstinent from 
smoking. Brief exposure 
(experimental session <1 hour). 
Only tested 1 model of ENDS. 
Dawkins 
(2013)87 
20 United 
Kingdom 
Mean 32 
years (SD 9), 
T  
No NR Exper Yes Did not include a comparison 
condition in which participants 
smoked cigarettes. Brief exposure 
(experimental session <1 hour). 
Only tested 1 model of ENDS. 
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Dawkins 
(2013)42 
1,347 33 
countries 
(72% in 
Europe) 
Mean 43 
years (SD 
12), M, 
ENDS users 
No Sep 2011-
May 2012 
Survey No Recruited through ENDS company 
websites.  
Dockrell 
(2013)62 
12,597 
in 2010; 
12,432 
in 2012 
United 
Kingdom  
 
Adults ≥18 
years, M 
 
No Feb 2010 
& Feb 
2012 
 
Survey No In 2010 survey, only current 
smokers were asked about ENDS 
use. Response rate not reported. 
Dockrell 
(2013)62 
1,380 United 
Kingdom  
Adults ≥18 
years, T 
No Apr 2010 Survey No Did not differentiate users’ and 
non-users’ attitudes about ENDS. 
Response rate not reported. 
Eissenberg 
(2010)54 
16 US (VA) Mean 30 
years (SD 
11), T, ENDS 
naïve  
No NR Exper NR Did not provide time for 
participants to become familiar 
with using ENDS. Brief exposure 
(experimental session <2 hours). 
Etter 
(2010)43 
81 Belgium, 
Canada, 
France, 
Switzerla
nd 
Mean 37 
years (range 
19-65), M, 
current or 
former 
ENDS users 
No Sep-Oct 
2009 
Survey No Recruited from smoking cessation 
websites, ENDS discussion 
forums, and websites that sell 
ENDS. 
Etter 
(2011)44 
3,587 US, 
France, 
United 
Kingdom
, 
Switzerla
nd, 
Canada, 
& others 
NR 
Median 41 
years , M  
No Mar-Oct 
2010 
Survey No Most recruitment from smoking 
cessation websites, ENDS 
discussion forums, and websites 
that sell ENDS. 
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Etter 
(2011)45 
31 US, 
France, 
United 
Kingdom
, 
Switzerla
nd, 
Canada, 
Italy 
Median 41 
years, M, 
ENDS users  
No Sep 2010- 
Jan 2011 
Survey  No Very low response rate (16%). 
Most recruitment from smoking 
cessation websites, ENDS 
discussion forums, and websites 
that sell ENDS. 
Farsalinos 
(2013)81 
1 NR 35 years, 
ENDS user, 
T 
No Aug-Nov 
2012 
Case 
report 
No Only 1 participant. Improvements 
in health may not be due to ENDS 
use. 
Farsalinos 
(2013)55 
80 Greece Mean 37-38 
years (range 
20-45), M, 
ENDS users 
and ENDS 
naïve  
No NR Exper NR Brief exposure (experimental 
session <1 hour). Only tested 1 
mode l of ENDS. 
Foulds 
(2011)46 
104 US (PA) Mean 34 
years (SD 9), 
ENDS users, 
T  
No 2011 Survey No Recruited from meeting of ENDS 
enthusiasts. 
Goniewicz 
(2012)64 
13,787  Poland Mean 18 
years (range 
15-24), M 
Yesa Sep 2010- 
Jun 2011 
Survey No Did not survey students living in 
rural areas with populations of 
<20,000 or attending private 
schools. 
Goniewicz 
(2013)47 
179 Poland 3% were 16-
18 years, 
18% 19-24 
years, 79% 
≥25 years, M, 
ENDS users  
No Fall 2009 
(approx.) 
Survey No Recruited from ENDS discussion 
forums and websites that sell 
ENDS. 
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Hua 
(2013)22 
73  NR 83% 19-45 
years, 17% 
age NR, 
separate 
groups of T 
& ENDS 
users  
No NR Observ No Use ENDS in YouTube videos 
may differ from use of ENDS in 
the general population. Not known 
whether participants were dual 
users. 
Hua 
(2013)83 
543 
posts  
US, 
Canada, 
United 
Kingdom
, Ireland, 
Australia, 
New 
Zealand, 
& others 
NR 
18-71 years 
(age NR for 
some users), 
ENDS users, 
M 
No Up through 
Jul 2011 
Observ No Could not validate accuracy of 
user reports. Reported effects may 
not be due to ENDS use. 
King 
(2013)60 
6,689 in 
2010; 
4,050 in 
2011 
US ≥18 years, M Yes Jul-Sep 
2010  
Jul-Aug 
2011 
Survey No Did not ask about current use of 
ENDS so could not assess dual 
use. Data collection methods 
varied. 
Kralikova 
(2012)51 
973 Czech 
Republic  
Mean 32 
years, T 
No Oct 2011 Structu
red 
intervie
ws 
NR Did not collect data on smoking 
history or amount of ENDS use.  
Li (2013)70  480 in 
2011; 
360 in 
2012 
New 
Zealand 
≥18 years, T Yes Jul-Sep 
2011 
Mar-May 
2012 
Survey No Treated purchase behavior as a 
proxy for use. High proportion of 
“don’t know” responses suggests 
lack of familiarity with ENDS. 
Response rate not reported. 
McCauley 
(2012)84 
1 US (OR) 42 years, 
ENDS user, 
tobacco use 
NR 
No NR Case 
report 
No Only 1 case. Health problems may 
not be due to ENDS use. 
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McMillen 
(2012)67 
3,240 US  14% 18-24 
years, 86% 
≥25 years, M 
Yes Sep-Nov 
2010 
Survey No Did not distinguish between ENDS 
and other emerging tobacco 
products when reporting on 
smoking cessation.  
McQueen 
(2011)50 
15 US (MO) Range 20-70 
years 
(approx.), 
ENDS users, 
T 
No Aug 2010  Qual 
interv 
No Recruited from meeting of ENDS 
enthusiasts. Varied and 
unsystematic interview 
methodology. 
Monroy 
(2012)85 
1 US (TX) 70 years, 
ENDS user, 
T 
No NR Case 
report 
No Only 1 case. Health problems may 
not be due to ENDS use. 
Pearson 
(2012)59 
2,649 US  ≥18 years, M Yes Jun 2010 Survey No None. 
Pearson 
(2012)59 
3,658 US  18-49 years, 
T 
Yesa Jan-Apr 
2010 
Survey No Did not ask about current use so 
could not estimate dual use. 
Pepper 
(2013)66 
228 US  11-19 years, 
M 
Yes Nov 2011 Survey No Males only. Very few smokers. 
Polosa 
(2011)75 
40 Italy Mean 43 
years (SD 9), 
T  
No Winter-
summer 
2010 
(approx.) 
Prosp 
trial 
Yes Uncontrolled trial. 33% lost to 
follow-up. 
Popova 
(2013)68 
1,836 US Mean 42 
years, T 
Yes Nov 2011 Survey No Potentially moderate response rate 
(58% completed screening; 41% of 
those qualified and completed the 
survey). Did not differentiate 
ENDS from other smokeless 
tobacco products when asking 
about reasons for using.  
Prochaska 
(2012)90 
153 
Twitter 
accounts 
Multiple 
countries 
(not 
listed) 
N/A No Jul 2007-
Aug 2010 
Observ No Only captured Tweets from 
accounts with user names that 
referenced smoking cessation. 
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Regan 
(2013)58 
10,587 
in 2009; 
10,328 
in 2010 
US  Adults ≥18 
years, M 
Yesa Apr-May 
2009 & 
Apr-May 
2010 
Survey NR Moderate response rates (50-52%). 
May underrepresent people 
without mailing addresses. Did not 
ask about current use of ENDS in 
2009. 
Richardson 
(2012)69 
1,310 US  Adults ≥18 
years, T 
Yes June 2010 Survey No Potentially moderate response rate 
(65% completed screening; 39% of 
those qualified and completed the 
survey). Did not assess current use 
of ENDS so could not determine 
dual use of ENDS.  
Siegel 
(2011)48 
216 NR Adults ≥18 
years, T, 
ENDS 
purchasers  
No Mar 2010 Survey NR Very low response rate (5%). 
Sampled from 1 ENDS brand 
during the company’s first weeks 
of operation. 
Sutfin 
(2013)71 
4,444 US (NC) Mean 21 
years (SD 3), 
M 
Yesa Fall 2009 Survey No Moderate response rate (41%). Did 
not distinguish former versus 
experimental smokers. 
Trumbo 
(2013)52 
244 US (CO) 19-22 years, 
M 
No Apr 2011 Survey No Participants were students in one 
lecture class at a university. 
Vansickel 
(2010)56 
32 US (VA) 18-55 years, 
T, ENDS 
naïve 
No NR Exper No Brief exposure (experimental 
session <2 hours). Did not provide 
time for participants to become 
familiar with using ENDS. 
Vansickel 
(2012)57 
20 US (VA) 18-55 years, 
T, not current 
ENDS users 
No NR Exper NR  Brief exposure (experimental 
session <3 hours). Only tested 1 
model of ENDS. Does not describe 
how participants were recruited. 
Vansickel 
(2013)79 
8 US (VA) 18-55 years, 
ENDS users, 
T 
No NR Exper No Brief exposure (experimental 
session 5 hours). Does not describe 
how ENDS users were recruited. 
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Vickerman 
(2013)74 
2,476 US (CT, 
LA, NE, 
NC, SC, 
TX) 
Mean 49 
years (SD 
13), T 
No Jan 2012-
Oct2012 
Survey No Low response rate (35%). Not 
known whether participants tried 
ENDS before calling quitline or 
whether participants used ENDS 
as part of their quit attempts. 
 
Note: ENDS = electronic nicotine delivery system. US = United States. N/A = not applicable. NR = not reported. SD = standard 
deviation. T = limited to current and former tobacco users. M = mix of tobacco users and non-users. Exper = experimental study 
design. Observ = observational study design. Prosp trial = prospective trial. Financial relationship = funded by or received free 
products from ENDS industry.  
 
aParticipants were randomly selected from clusters chosen purposively. bCombination of probability and quota sampling methods. 
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Figure 1.1. Flow diagram of literature search and article identification. 
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CHAPTER 2: SPECIFIC AIMS AND PREDICTIONS 
This dissertation uses a diffusion of innovation (DOI) framework93 to understand 
awareness and perceptions of e-cigarettes, as well as responses to messages about e-
cigarettes. E-cigarettes embody two key hallmarks of an innovation. They have a relative 
advantage over the product they supersede (i.e., cigarettes) because they are or are perceived 
to be healthier, cheaper, or able to be used in smoke-free situations.94 E-cigarettes also 
exhibit compatibility with users’ needs and experiences because they mimic some aspects of 
smoking, including relatively fast nicotine delivery and the feel of inhalation.94 The DOI 
framework describes five steps in the innovation adoption process: knowledge (an individual 
learns about e-cigarettes), persuasion (the individual forms an attitude about e-cigarettes), 
decision (the individual chooses whether to use e-cigarettes), implementation (the individual 
begins to use e-cigarettes), and confirmation (the individual seeks reinforcement of or 
decides to reject the previous choice to use e-cigarettes).  
My specific aims for this dissertation, described in the context of the DOI framework, 
are as follows.  
 
Specific Aim 1 (Paper 1) 
Document and examine differences in smokers’ and non-smokers’ awareness of e-
cigarettes and the most frequent ways that they have heard of e-cigarettes. 
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The proposed research will assess whether all survey respondents, both smokers and 
non-smokers, have heard of e-cigarettes and the channels through which they have heard of 
them. 
Prediction 1.1: Nearly all U.S. adults will be aware of e-cigarettes.  
In 2009, 16% of U.S. adults had heard of e-cigarettes.58 By 2011, that figure rose to 
58%.60 Between 2010 and 2013, the media covered e-cigarettes extensively, and there has 
been an increase in online searching for information about e-cigarettes.5,18,19,95 Based on 
these trends, I believe that awareness has continued to rise and, as of March 2013, nearly all 
U.S. adults will have heard of e-cigarettes. Given the variety of channels of information 
about e-cigarettes (the Internet, popular media, interpersonal, etc.), I anticipate that most 
respondents who have heard of e-cigarettes will report having heard of them through multiple 
channels. I also anticipate that smokers will be more likely to be aware of e-cigarettes than 
non-smokers, as has been found consistently in other studies.58,59 
Prediction 1.2: Among those who have heard of e-cigarettes, smokers and e-cigarette users 
will be more likely to report learning about e-cigarettes from someone who uses e-cigarettes 
than will non-smokers and non-users. 
Most e-cigarette users are or were smokers.43,44,46,50,58,59 Individuals who smoke are 
especially likely to have family members and friends who smoke.96 The clustering of 
smokers within families is due in part to genetic factors.97 Homophily (i.e., developing 
relationships with others who are similar to you) and social learning contribute to the 
clustering of smokers in peer groups.98,99 Thus, if one smoker begins using an e-cigarette, 
other smokers in that person’s network are likely to see or hear about it, resulting in frequent 
reports from smokers and e-cigarette users that they heard information about e-cigarettes 
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through someone who has used them. As described in the DOI framework, interpersonal 
communication channels are particularly important for connecting early adopters of an 
innovation (smokers who use e-cigarettes) with other potential adopters.93 
Prediction 1.3: Adults less than 30 years old will be more likely to hear about e-cigarettes 
from Internet sources (an e-cigarette Web site, online ad, Twitter, or Facebook) than will 
adults ages 30 and over. 
Adults ages 18–29 are more likely to use the Internet, own devices that access the 
Internet, watch videos on YouTube, and be active on Twitter and Facebook than adults ages 
30 and over.100-102 Each of those online channels is a potential source of information about e-
cigarettes. Thus, I believe that adults under age 30 will be more likely to have heard about e-
cigarettes from an online source than those ages 30 and over. The Internet is a particularly 
important channel from a DOI perspective because it combines mass media (the key channel 
for increasing knowledge) and interpersonal communication (the key channel for influencing 
adoption decisions).  
As part of this paper, I will also examine other differences in sources of information, 
particularly differences by gender, race and ethnicity, and socioeconomic status. I do not 
have a priori predictions about these disparities. 
 
Specific Aim 2 (Paper 2) 
Compare smokers’ perceptions of the health risks of e-cigarettes to the health risks of 
other traditional and novel tobacco products. 
Risk perceptions are associated with a variety of health protective behaviors. For 
example, a meta-analysis by found that perceived risk likelihood, susceptibility, and severity 
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were all moderately but significantly related to adult vaccination.28 Perceived risk of 
developing cancer is associated with having had a mammogram, sigmoidoscopy, or 
colonoscopy.103 
The relationship between smoking risk perception and smoking attitudes and 
behaviors is somewhat more complicated. Concern about the health consequences of 
smoking motivates smokers to try to quit.104 Smokers know that smoking cigarettes is 
harmful to one’s health, but they may not fully appreciate all of the relevant risks.105 For 
example, respondents in a national survey underestimated lung cancer mortality rates and 
overestimated duration of survival after diagnosis.105 When asked about their risk, smokers 
often express unrealistic optimism about their likelihood of developing smoking-related 
illness or their ability to quit smoking.106,107 The proposed research will assess current 
smokers’ risk beliefs about their personal likelihood of developing three specific health 
problems (lung cancer, oral cancer, and heart disease) in the next 10 years due to regular use 
of different tobacco products.  
Prediction 2.1: Smokers will report believing that, relative to regular cigarettes, e-cigarettes 
are less likely to cause health harms to them personally. 
The objective long-term safety of e-cigarettes is unknown, although the product is 
clearly less harmful than cigarettes.108 E-cigarette users,43,44,46,47,50 who are mostly current 
and former smokers, as well as smokers who do not use e-cigarettes59 consistently report 
believing that e-cigarettes are less harmful than regular cigarettes. Although smokers may not 
be able to articulate specific reasons (e.g., e-cigarette use does not produce combustion-
related carcinogens), I predict that smokers surveyed in the proposed research will report 
perceiving that regular cigarettes are more likely to cause lung cancer, oral cancer, and heart 
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disease than e-cigarettes. I believe that smokers will not distinguish among these health 
conditions because they see e-cigarettes as having a consistent relative advantage over 
cigarettes.  
Prediction 2.2: E-cigarette users will have stronger beliefs than will non-users that e-
cigarettes are less harmful than regular cigarettes.  
Subjective expected utility (SEU), a key concept in theories of decision-making, is 
the perception of the extent to which the consequences of a behavior are desirable. For health 
behaviors, SEU represents the difference in perceived harms that result if there is no change 
in behavior versus the adoption of a protective measure.109,110 In the case of e-cigarettes, a 
smoker’s belief that e-cigarettes are less likely to cause health problems than regular 
cigarettes is an indicator that they perceive the use of e-cigarettes as having positive SEU. 
Existing research on the use of alternative nicotine products demonstrates a 
relationship between beliefs about reduced harm (akin to positive SEU) and use of the 
product. For example, relative to those who believed than snus were as harmful as or more 
harmful than cigarettes, smokers who believed (correctly) that snus are less harmful than 
cigarettes were more willing to try snus in a future quit attempt.111 Based on predictions 
related to SEU and this prior research on alternative tobacco products, I posit that beliefs 
about lower likelihood of health problems will be associated with current use of e-cigarettes. 
Because of the cross-sectional nature of the proposed research, I cannot specify the 
direction of the causal relationship for this prediction. As noted by Weinstein, Brewer, and 
others, once people have carried out a precautionary behavior, in this case using e-cigarettes, 
their risk perceptions may have changed and it is not possible to establish whether their risk 
perceptions were causes of or responses to the behavior.28,112  
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Prediction 2.3: Smokers will view e-cigarettes as less likely to cause health problems than 
traditional smokeless tobacco products (moist snuff, dip, spit, or chewing tobacco). 
The survey will measure the perceived likelihood of harms from regular use of 
traditional smokeless tobacco as well as e-cigarettes, snus, and dissolvable tobacco. Most 
smokers and non-smokers typically believe that smokeless tobacco is roughly as harmful to 
health as regular cigarettes.113-115 Health authorities like the Centers for Disease Control and 
Prevention (CDC) and American Cancer Society have presented the message that using 
smokeless tobacco is as dangerous as smoking cigarettes, and the public has absorbed this 
message.116 Indeed, one of the smokeless warning labels required by the Tobacco Control 
Act states, “This product is not a safe alternative to cigarettes,” even though there is evidence 
that smokeless tobacco is less harmful than cigarettes.117,118 Smokers may not view 
smokeless tobacco as having the same health-related relative advantage over cigarettes that e-
cigarettes do. Therefore, I expect to see a similar pattern to the one described in prediction 
2.1: Smokers will perceive that e-cigarettes are safer than traditional smokeless tobacco 
products.  
I do not have an a priori prediction about perceptions of snus and dissolvables relative 
to e-cigarettes, partly because knowledge of and messages about these products are still 
relatively uncommon. In a nationally representative survey of U.S. adults in 2009, a large 
proportion of respondents were unsure about the dangers of using snus and dissolvables 
relative to regular cigarettes.119 Thus, I do not make a prediction about how they will rate the 
risks posed by these products relative to e-cigarettes.  
43 
Specific Aim 3 (Paper 3) 
Assess the effects of e-cigarette testimonial messages on interest in trying e-cigarettes 
among smokers who have not previously tried e-cigarettes. 
As part of this proposed research, current smokers who have not previously tried e-
cigarettes will be randomly assigned to view one advertisement promoting a reason to use e-
cigarettes. The messages in the advertisements will promote e-cigarettes using one of three 
comparison types based on the diffusion of innovation framework: difference (i.e., relative 
advantage), similarity (i.e., compatibility), or no comparison (control condition). The 
respondent will then indicate how much hearing the message makes them want to try e-
cigarettes. I anticipate that desire to try e-cigarettes will vary by experimental condition. I 
have the following specific hypotheses. 
Prediction 3.1: Among smokers, messages that include a comparison between e-cigarettes 
and regular cigarettes will be associated with greater interest in trying e-cigarettes than 
messages that do not include a comparison. 
Humans rely on comparisons to process the information we encounter.120 
Comparative thinking increases the efficiency of our thinking (making it faster without 
sacrificing accuracy)121 and makes us more confident about our judgments.122 Many of the 
current messages about e-cigarettes are directed toward smokers and emphasize how e-
cigarettes are similar to or different from regular cigarettes. We can see this focus in popular 
media coverage123 and e-cigarette advertising.124 In general, comparative advertising 
increases consumer attention, message awareness, brand awareness, favorable brand 
attitudes, purchase intention, and purchase behavior relative to non-comparative 
advertising.125 Comparative advertising is particularly effective when the sponsored brand in 
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the advertisement is new to the market (i.e., like e-cigarettes of any brand) and the 
comparison brand is a market leader (i.e., like regular cigarettes of any brand).125  
Prediction 3.2: Among smokers, comparative messages that focus on differences between e-
cigarettes and regular cigarettes (relative advantage) will be associated with greater interest 
in trying e-cigarettes relative to comparative messages that focus on similarities 
(compatibility). 
Relative advantage and compatibility are both desirable qualities in an innovation, but 
I believe that messages emphasizing relative advantage will be most effective in generating 
interest in this particular innovation. Regular cigarettes, the product that e-cigarettes 
supersede, have negative connotations. Even smokers see cigarettes as unhealthy126 and 
stigmatized.127,128 Indeed, e-cigarette users’ two most frequently reported reasons for using 
(i.e., improved health and help with quitting smoking) focus on the differences between e-
cigarettes and regular cigarettes.94 Fewer users report that e-cigarettes’ similarity to regular 
cigarettes motivates use.43   
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CHAPTER 3: HOW U.S. ADULTS FIND OUT ABOUT ELECTRONIC 
CIGARETTES: IMPLICATIONS FOR PUBLIC HEALTH MESSAGES 
Introduction 
Electronic cigarettes, also called e-cigarettes or electronic nicotine delivery systems, 
are battery-operated devices that produce vapor by heating a cartridge containing nicotine, 
flavoring, and humectants. Many researchers and public health advocates are concerned 
about e-cigarettes’ safety,2,3 possible use as a gateway to future smoking,6,129 and potential to 
prevent smokers from trying proven cessation tools. Evidence of e-cigarettes’ ability to help 
smokers quit is suggestive but not definitive.94,130 The federal government does not currently 
regulate e-cigarettes but intends to do so through the Food and Drug Administration.131  
E-cigarette awareness among U.S. adults has increased from 16% in 200958 to 75% in 
2012.132 Ever use has also increased from 1% of U.S. adults in 200958 to 8% in 2012.132 
Current and former smokers are more likely to be aware of and use e-cigarettes than never 
smokers.58-60,132  
Our study expands on past research by documenting how adults learn about e-
cigarettes, describing how those channels might be used for public health communication, 
and discussing the potential need to regulate marketing on those channels. We tested three 
predictions. First, we predicted that hearing about e-cigarettes from a person who uses them 
would be more common among smokers than non-smokers, given that smokers have higher 
rates of e-cigarette use than non-smokers, and smokers gather together in social and family 
groups (i.e., homophily).96 Second, we predicted that hearing about e-cigarettes from a 
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person who uses them would be more common among e-cigarette users than non-users 
because e-cigarette users gather with other users (homophily) and exchange information 
about the product.43,46,49 Third, we predicted that young adults would be more likely to hear 
about e-cigarettes through online sources because young adults are more likely than older 
adults to use the Internet and social media.100,101  
 
Methods 
Sample 
This study relied on data collected from U.S. adults (age ≥18) in a March 2013 online 
survey as part of the Tobacco Control in a Rapidly Changing Media Environment study that 
examined the relationship between recall of receiving and sharing tobacco-related 
information and smoking attitudes, beliefs, and behavior. Most respondents (75%) were 
members of KnowledgePanel, a nationally representative online survey panel constructed 
using random-digit dialing supplemented by address-based sampling.133 To recruit the rest of 
the sample, the survey company screened people who clicked on online ads and quota 
matched them to the probability sample based on demographic and tobacco use 
characteristics. The survey company also screened names and addresses and removed 
duplicates before inviting them to complete the survey. Non-responders received up to four 
reminders, and all participants provided consent online before taking the survey. Sixty-one 
percent of invited KnowledgePanel members completed the screening, and 97% of eligible 
respondents completed the survey. Response rates for the convenience sample cannot be 
calculated because there is no known sampling frame. The study received institutional review 
board approval. 
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Measures 
The survey described e-cigarettes while displaying generic images of the product: 
“An e-cigarette looks like a regular cigarette, but it runs on a battery and produces vapor 
instead of smoke. There are many types of e-cigarettes. Some common brands are Smoking 
Everywhere, NJOY, Blu, and Vapor King.” Next, one item assessed awareness of e-
cigarettes: “Before today, had you ever heard of e-cigarettes?” (yes/no). 
Respondents who had heard of e-cigarettes received a question about the sources of 
their awareness, “From which of the following sources have you ever heard about e-
cigarettes?”: another person; online; an ad on TV; an ad in a newspaper or magazine; a news 
story on TV or in a newspaper or magazine; and seeing them for sale in stores, including gas 
stations. Respondents who had heard about e-cigarettes from another person received the 
question, “Who did you hear about e-cigarettes from?”: a friend or family member who uses 
e-cigarettes, a friend or family member who does not use e-cigarettes, someone else who uses 
e-cigarettes, and someone else who does not use e-cigarettes. Respondents who had heard 
about e-cigarettes online received the question, “Where did you hear about e-cigarettes 
online?”; response options were Twitter, an ad or user on Facebook, an ad or user on 
YouTube, an ad on some other website, a website that sells e-cigarettes, and an online news 
source. 
The survey assessed demographics and smoking status. Current smokers received 
questions about intentions to quit (“Do you plan to quit smoking for good…?”: in the next 7 
days, in the next 30 days, in the next 6 months, in the next year, more than one year from 
now, or I do not plan to quit smoking for good) and previous quit attempts (“During the past 
year, have you stopped smoking for one day or longer because you were trying to quit 
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smoking for good?”: yes/no). We conducted cognitive interviews with 16 participants during 
survey item development and pre-tested the revised items with 160 respondents.  
Data Analysis 
Analyses used Stata Version 12 (svy commands to account for the complex survey 
design), two-tailed statistical tests, and a critical alpha of .01. We examined bivariate 
associations between respondent characteristics and awareness of e-cigarettes using logistic 
regression, and included statistically significant correlates in a multivariate model. To 
address our predictions, we conducted three multivariate logistic regressions, each adjusted 
for significant bivariate correlates and using source of awareness as the outcome. The 
regressions assessed whether (1) current smokers (smoke every day or some days) and 
former smokers (smoked more than 100 cigarettes in their lifetime but not currently smoking) 
were more likely than never smokers (smoked fewer than 100 cigarettes) to have heard about 
e-cigarettes from someone who uses them (a combination of the responses “a friend or family 
member who uses e-cigarettes” and “someone else who uses e-cigarettes”); (2) e-cigarette 
users were more likely than non-users to hear about e-cigarettes from someone who uses 
them; and (3) respondents ages 30 and younger were more likely than those over age 30 to 
hear about e-cigarettes online. 
Frequencies are unweighted, and percentages and analyses are weighted. Post-
stratification sample weights accounted for study design, including the combination of the 
probability and non-probability samples, and representativeness of the sample compared to 
the U.S. population.  
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Results 
More than half of respondents (52%) were never smokers, 28% were former smokers, 
and 21% smoked every day or some days (Table 3.1). Among current smokers, 54% intended 
to quit smoking in the next year. Most respondents were non-Hispanic White (68%) and had 
at least some college education (57%). The mean age was 47 years (SD 27). Eighty-six 
percent of U.S. adults had heard of e-cigarettes in 2013. Among those who were aware of e-
cigarettes, 83% had never tried them, 11% were former users, and 6% were current users. 
Correlates of Awareness 
In multivariate analysis, former smokers (90% aware) and current smokers (95%) 
were more likely to have heard of e-cigarettes than never smokers (81%, both p<.001) (Table 
3.2). Greater awareness was associated with gender (89% of males vs. 84% of females, 
p<.01), higher education (88% of those with some college education and 87% of those with 
college or more vs. 78% of those with less than a high school education, both p<.001), and 
race (80% of non-Hispanic Black, 77% of non-Hispanic other race, and 80% of Hispanic 
adults vs. 89% of non-Hispanic White adults; all p<.001). Awareness decreased with age 
(p<.001).  
Sources of Awareness 
The most frequent way that adults had heard of e-cigarettes was through another 
person (34% of never, 39% of former, and 48% of current smokers) (Figure 3.1), by seeing 
them for sale in stores (22% of never, 27% of former, and 47% of current smokers), and by 
seeing them advertised on television (31% of never, 35% of former, and 40% of current 
smokers). Fewer respondents endorsed the Internet (12% of never, 12% of former, and 28% 
of current smokers) as a source of awareness.  
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As predicted, current smokers (83% aware) were more likely to have heard about e-
cigarettes from an e-cigarette user than former smokers (78%, p<.01) or never smokers (72%, 
p<.001). Consistent with our second prediction, 85% of ever e-cigarette users who heard 
about e-cigarettes from another person said that that person used e-cigarettes, compared to 
74% of those who had never used e-cigarettes (p<.001). Finally, as predicted, respondents 
over age 30 were less likely to have heard about e-cigarettes through the Internet than those 
ages 30 and younger (14% vs. 23%, p<.001).  
 
Discussion 
Most U.S. adults (86%) had heard of e-cigarettes by 2013, continuing the increasing 
trend from 2009 (Figure 3.2). Demographic groups with higher smoking rates in the general 
population (e.g., men, non-Hispanic Whites)72 were often more likely to be aware of e-
cigarettes in our study, although this pattern was not consistent for education. This 
discrepancy may reflect exposure to outlets selling e-cigarettes, which are more widely 
available in high socioeconomic status neighborhoods.134  
Interpersonal communication was an important source of information among current 
and former smokers. Because of homophily,96 smokers often associate with other smokers, 
who appear to be important sources of information about e-cigarettes. Similarly, e-cigarette 
users often congregate with other users,43,46,49 so product information likely spreads through 
those connections.  
E-cigarettes have a strong online presence,21,135 which helps to explain why more than 
one-quarter of smokers learned about e-cigarettes online. The Internet may play an important 
role by reinforcing word of mouth messages, providing additional information as follow-up 
51 
to personal conversations, or priming people to participate in conversations about e-
cigarettes. Our results were consistent with our prediction that online sources were more 
common for adults under 30, who are more likely than those over 30 to use the Internet and 
social media.100,101 
These results have important implications for public health communication. First, 
interpersonal discussion is a key source of information, so future efforts should consider 
including grassroots “word of mouth” strategies. Televised advertising, a frequent source of 
information, could be used to communicate public health messages. Given that seeing e-
cigarettes for sale in stores was a common source of awareness and point-of-sale cigarette 
marketing is already known to influence smoking behavior,136 warning labels should be 
clearly displayed on the products and their advertising at the point of sale, as is currently 
done for cigarettes and smokeless tobacco products. Based on our findings, web-based 
communications could be helpful to reach young adults 18-30. Finally, because these same 
routes of communication also serve as marketing channels, the public health community 
should closely track them and, as necessary, consider regulation to prevent targeted 
marketing to youth, non-tobacco users, and other at-risk groups. For example, if youth 
frequently learn about e-cigarettes from televised advertising or such advertising 
renormalizes the image of smoking, the FDA might promulgate regulations to restrict or ban 
such ads on television. 
Limitations include the study’s cross-sectional design that precluded examining 
whether different sources of awareness predicted initiation or changes in e-cigarette use. We 
did not study first source of awareness, the content of the information people received, or 
their perceptions of its validity. Future studies will also need to establish the generalizability 
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of our findings to youth and to newer types of e-cigarettes, including tank models. While we 
recruited a supplementary convenience sample, we quota matched them to the probability 
sample on demographic and tobacco use characteristics.  
In sum, awareness of e-cigarettes has increased rapidly in recent years, but we do not 
know whether the information that people are receiving is accurate or appropriate. Our 
results suggest that some channels (e.g., word of mouth, television, point-of-sale displays) 
may be more useful for spreading timely, accurate information about e-cigarettes than others.  
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Table 3.1. Sample Characteristics (n=17,522)  
 
Characteristic n Weighted % 
Respondent   
Gender   
Male 7,819 48.0 
Female 9,703 52.0 
Age, mean (SD)  46.9 (26.5) 
Education   
Less than high school 697 6.8 
High school 3,901 36.1 
Some college 6,342 31.2 
Bachelor’s degree or higher 6,582 25.9 
Cigarette smoking status   
Never smokera 6,755 51.8 
Former smokerb 4,160 27.5 
Current smokerc 6,607 20.7 
Intention to quit smokingd   
In the next year 3,683 53.7 
More than 1 year from now 918 15.0 
Do not plan to quit 2,006 31.3 
E-cigarette use and awareness   
Not aware 1,951 13.8 
Aware but never tried 11,661 71.5 
Former user 2,305 9.6 
Current user 1,605 5.1 
Race/ethnicity   
White, non-Hispanic 13,931 68.1 
Black, non-Hispanic 1,317 11.5 
Other, non-Hispanic 556 5.5 
Hispanic 1,246 13.5 
>1 race, non-Hispanic  472 1.4 
Marital status    
Married or living with partner 10,697 62.0 
Never married 3,215 21.6 
Divorced or separated 2,668 12.0 
Widowed 942 4.3 
Employment   
Working 9,351 57.0 
Not working: laid off or looking for 
work 
1,560 10.0 
Not working: retired, disabled, or other 6,611 33.1 
Household   
Region    
Northeast 3,029 18.2 
Midwest 4,478 22.2 
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South 6,037 37.3 
West 3,978 22.4 
Household income   
Less than $25,000 3,716 18.7 
$25,000 - $49,999 4,739 23.6 
$50,000 - $74,999 3,613 19.6 
$75,000 - $99,999 2,440 18.5 
$100,000 or more 3,014 19.5 
High speed Internet access   
Yes 16,525 92.9 
No 997 7.1 
 
Note. Frequencies are unweighted. aSmoked fewer than 100 cigarettes in lifetime. bSmoked 
100 or more cigarettes in lifetime but does not currently smoke. cSmokes cigarettes some 
days or every day. dAmong current smokers (n=6,607). 
 
 
 
 
 
 
 Table 3.2. Correlates of Awareness of E-Cigarettes (n=17,522) 
 
 
 
Number aware of e-
cigarettes / Total number 
in category (weighted %) 
Bivariate Multivariate  
 
 n (%) OR  (95% CI) OR  (95% CI)  
Overall 15,571 / 17,522 (86.2)     
       
Respondent characteristics       
Gender       
Male (Ref) 7,089 / 7,819 (88.6) 1.00 - 1.00 - 
 Female 8,482 / 9,073 (83.9) 0.67 (0.58, 0.78)** 0.76 (0.65, 0.89)* 
Age   0.99 (0.99, 1.00)* 0.99 (0.98, 0.99)** 
Education       
Less than high school (Ref) 585 / 697 (78.1) 1.00 - 1.00 - 
High school 3,424 / 3,901 (85.3) 1.64 (1.22, 2.20)* 1.51 (1.10, 2.09) 
Some college 5,777 / 6,342 (88.1) 2.08 (1.54, 2.80)** 1.91 (1.37, 2.65)** 
Bachelor’s degree or higher 5,785 / 6,582 (87.1) 1.91 (1.42, 2.55)** 1.99 (1.42, 2.80)** 
Cigarette smoking status       
Never smokera (Ref) 5,551 / 6,755 (80.6) 1.00 - 1.00 - 
Former smokerb 3,709 / 4,160 (90.1) 2.19 (1.84, 2.62)** 2.50 (2.07, 3.03)** 
Current smokerc 6,311 / 6,607 (94.9) 4.47 (3.60, 5.56)** 4.93 (3.93, 6.20)** 
Race/ethnicity       
White, non-Hispanic (Ref) 12,564 / 13,931 (89.2) 1.00 - 1.00 - 
Black, non-Hispanic 1.094 / 1,317 (80.1) 0.49 (0.39, 0.61)** 0.55 (0.43, 0.70)** 
Other, non-Hispanic 459 / 556 (76.8) 0.40 (0.30, 0.54)** 0.37 (0.26, 0.51)** 
Hispanic 1,036 / 1,246 (79.8) 0.48 (0.39, 0.59)** 0.47 (0.37, 0.60)** 
>1 race, non-Hispanic  418 / 472 (86.4) 0.77 (0.49, 1.21) 0.75 (0.48, 1.16) 
Marital status        
Married or living with partner 
(Ref) 
9,493 / 10,697 (86.2) 1.00 -   
Never married 2,865 / 3,125 (85.4) 0.94 (0.77, 1.14)   
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 Divorced or separated 2,424 / 2,668 (89.1) 1.31 (1.05, 1.64)   
Widowed 789 / 942 (81.9) 0.72 (0.55, 0.96)   
Employment       
Working (Ref) 8,493 / 9,351 (88.0) 1.00 - 1.00 - 
Not working: laid off or looking 
for work 
1,390 / 1,560 (83.8) 0.71 (0.54, 0.92)* 0.79 (0.59, 1.04) 
Not working: retired, disabled, or 
other 
5,688 / 6,611 (83.7) 0.70 (0.60, 0.81)** 0.85 (0.71, 1.03) 
Household       
Region        
Midwest (Ref) 4,035 / 4,478 (89.2) 1.00 -  1.00 - 
Northeast 2,674 / 3,029 (85.4) 0.71 (0.57, 0.89)* 0.77 (0.61, 0.98) 
South 5,359 / 6,037 (85.9) 0.74 (0.61, 0.90)* 0.87 (0.71, 1.08) 
West 3,503 / 3,978 (84.2) 0.65 (0.52, 0.80)** 0.84 (0.67, 1.07) 
Household income       
Less than $25,000 (Ref) 3,271 / 3,716 (84.0) 1.00 - 1.00 - 
$25,000 - $49,999 4,200 / 4,739 (84.8) 1.07 (0.86, 1.32) 0.98 (0.77, 1.24) 
$50,000 - $74,999 3,245 / 3,613 (87.5) 1.33 (1.06, 1.68) 1.13 (0.87, 1.47) 
$75,000 - $99,999 2,160 / 2,440 (86.6) 1.23 (0.97, 1.57) 1.03 (0.78, 1.36) 
$100,000 or more 2,695 / 3,014 (88.3) 1.44 (1.14, 1.81)* 1.25 (0.94, 1.66) 
High speed Internet access       
No (Ref) 818 / 997 (78.3) 1.00 - 1.00 - 
Yes 14,753 / 16,525 (86.8) 1.82 (1.42, 2.33)** 1.40 (1.06, 1.84) 
 
Note. Multivariate model contains all correlates significant (p<.01) in bivariate models. OR = odds ratio. CI = confidence interval. Ref 
= reference category. Frequencies are unweighted; the other statistics are from weighted analyses. *p<.01. **p<.001. 
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Figure 3.1. Channels of awareness of e-cigarettes among current smokers (n=6,311), former 
smokers (n=3,709), and never smokers (n=5,551) who have heard of e-cigarettes. 
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Figure 3.2. Increase in awareness of e-cigarettes among U.S. adults: 16% in 2009,58 37% 
(mean) in 2010,58-60 58% in 2011,60 75% in 2012,132 and 86% in 2013. 
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CHAPTER 4: SMOKERS’ PERCEPTIONS OF THE HEALTH RISKS OF 
ELECTRONIC CIGARETTES COMPARED TO REGULAR CIGARETTES AND 
OTHER TOBACCO PRODUCTS 
Introduction 
Although traditional cigarettes remain the most popular tobacco product in the U.S. 
(19% of U.S. adults were current smokers in 2010),72 there are many other non-medicinal 
nicotine and tobacco products currently available in the U.S. market, including electronic 
cigarettes (e-cigarettes), snus, dissolvable tobacco, and traditional smokeless tobacco. These 
other tobacco products (OTPs) vary in terms of their popularity and mode of nicotine 
delivery. E-cigarettes are battery-powered devices that produce vapor by heating a solution 
containing nicotine, humectants, and flavoring, although non-nicotine versions are available. 
The percentage of U.S. adults who have tried e-cigarettes in the past (“ever users”) rose from 
1% in 200958 to 15% in 2013,137 and rates are higher among smokers. Half of current 
smokers in a 2013 nationally representative U.S. survey had ever tried e-cigarettes, and 80% 
of e-cigarette ever users also smoked.137 Snus are packets of moist tobacco that users place 
between their gums and cheeks. About 4% of U.S. adults surveyed in 2012 had ever tried 
snus.132 Dissolvable tobacco typically comes in the form of sticks, strips, or orbs; fewer than 
1% of U.S. adults had ever tried dissolvable tobacco as of 2010.67 Compared to e-cigarettes, 
snus, and dissolvable tobacco, many more people in the U.S. (18% of those over age 12 in 
2012)138 have ever tried traditional smokeless tobacco, including chewing tobacco and snuff. 
Although rates of cigarette smoking among U.S. adults have declined, rates of use of other 
tobacco products have increased.72,94,139 
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Because products like e-cigarettes, snus, dissolvable tobacco, and traditional 
smokeless tobacco do not rely on combustion, they do not produce the same harmful 
chemicals and particles that regular cigarettes do and are therefore considered by scientists to 
be less dangerous.140,141 However, non-combustible tobacco products are not entirely without 
potential harm. For example, certain models of e-cigarettes have been found to contain 
carcinogenic tobacco-specific nitrosamines,142 and some researchers are concerned about the 
long-term impact of inhaling humectants like propylene glycol.11 Harm reduction advocates 
emphasize the need to communicate information about the relative harm of non-combustible 
products compared to cigarettes, not merely the absolute harm of such products.116,143 In 
contrast, some tobacco control messages focus on the basic idea that “there is no safe tobacco 
product.”144  
The degree to which the public believes that OTPs are less harmful than regular 
cigarettes has important implications for their use. Expectancy value theories such as the 
Health Belief Model,145 as well as past studies examining a variety of behaviors (e.g., 
vaccination28 and cancer screening103) suggest that risk beliefs (e.g., perceived likelihood of 
harm) can drive health behavior. Research shows that these beliefs can affect smoking 
behavior, although not consistently. For example, concern about the health consequences of 
smoking motivates many smokers to try to quit,146 and some smokers switched to “light” 
cigarettes because they believed these were healthier than regular cigarettes.147 However, 
across multiple prospective studies, the stated reason for wanting to quit smoking (i.e., health 
concerns versus other concerns) was rarely associated with success in quitting.104 Thus, there 
is a need to understand whether smokers might be motivated to use OTPs because they 
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perceive those products to be less harmful and whether that motivation produces actual 
behavioral change. 
We sought to understand how U.S. adult smokers perceived the risks of using 
cigarettes and OTPs. We focused on smokers because they are more likely than non-smokers 
to use OTPs. First, we hypothesized that smokers would view e-cigarettes as less likely to 
cause health problems than cigarettes (Hypothesis 1). Consistent with Rogers’ diffusion of 
innovation theory,93 smokers may see a novel product (e-cigarettes) as an improved 
replacement for a traditional product (regular cigarettes) and thus would see the latter as 
riskier to use. We also hypothesized that smokers would see cigarettes as more likely to 
cause lung cancer than smokeless tobacco, snus, and dissolvable tobacco, but less likely to 
cause oral cancer (Hypothesis 2). Some people base their beliefs about a tobacco product’s 
health risks in part on how it comes into contact with the user’s body,89 and smokeless 
tobacco, snus, and dissolvable tobacco are placed directly against the cheeks, tongue, or 
gums. In addition to testing these hypotheses, we conducted exploratory analysis comparing 
e-cigarettes to alternative OTPs. 
 
Methods 
Sample 
The Tobacco Control in a Rapidly Changing Media Environment (TCME) project 
gathered data from a national sample of 17,522 U.S. adults (6,607 current smokers, 4,160 
former smokers, and 6,755 never smokers). The TCME survey, conducted online in March 
2013, assessed recall of and searching for tobacco-related information, as well as the 
relationship between that information and tobacco use behaviors, beliefs, and attitudes. The 
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majority of participants (75%) were recruited from KnowledgePanel, a nationally 
representative online survey panel that recruits participants through random-digit dialing, 
supplemented by address-based sampling to capture cell phone–only households.133 Of 
34,097 KnowledgePanel members sampled, 61% (n=20,907) completed the screening. 
Among eligible respondents (n=13,531), 97% (n=13,144) completed the survey. Other 
participants were recruited from convenience samples of online market research panels, using 
quota sampling to match demographic characteristics of a nationally representative sample; 
response rate data from the market research panels are not available. For this study, we report 
data from current smokers (n=6,607). Institutional review boards at the National Cancer 
Institute and the University of Illinois at Chicago approved the study. 
Measures 
Smokers responded to an item about the health risks of cigarettes: “How likely do you 
think it is that smoking cigarettes regularly would cause you to develop each of the following 
in the next 10 years? (If you’re not sure, please give us your best guess).” The health 
conditions were lung cancer, heart disease, and mouth or throat cancer (referred to as “oral 
cancer” hereafter). Respondents rated their likelihood of developing these health conditions 
on a 5-point response scale (“not at all likely” (coded as 1) to “extremely likely” (5)). We 
averaged the ratings of the likelihood of developing the three health conditions to create a 
scale (α= 0.95).  
We then randomly assigned smokers to receive another question about e-cigarettes, 
snus, dissolvable tobacco (sticks, strip, orbs), or traditional smokeless tobacco (moist snuff, 
dip, spit, chew). To conserve space on the survey, participants answered this item about only 
one product. Participants viewed a description of the product before responding to the item. 
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The item read “Imagine that you stopped smoking regular cigarettes and only used [product]. 
How likely do you think it is that using [product] regularly would cause you to develop each 
of the following in the next 10 years? (If you’re not sure, please give us your best guess.)” 
The health conditions and response scale were the same as in the parallel item about regular 
cigarettes. We created a composite perceived risk measure for e-cigarettes by averaging the 
ratings of the likelihood of developing the three health conditions for that product (α= 0.97). 
To assess understanding of item wording and ease of responding to survey items, we 
conducted cognitive interviews with 16 people and then pre-tested the revised survey with 
160 respondents. For all variables, we recoded missing scores (<0.5% for each item) to the 
mean of that item.  
Data Analysis 
To address Hypothesis 1, we conducted within-subjects analyses, using paired t-tests 
to compare the perceived risk of each of the three health problems for cigarettes versus e-
cigarettes. To examine the robustness of the findings comparing perceived risk for cigarettes 
and e-cigarettes, we repeated the t-tests for demographic subgroups (e.g., only males, only 
smokers who intended to quit smoking in the next year).  
To address Hypothesis 2, we repeated the paired t-tests to compare cigarettes to 
smokeless tobacco, snus, and dissolvable tobacco for each of the three health problems. For 
the exploratory analysis comparing e-cigarettes to the alternative OTPs we conducted a 
between-subjects analysis, using linear regression to examine whether the perceived risk of 
developing lung cancer varied by OTP type (e-cigarettes, smokeless tobacco, snus, and 
dissolvable tobacco). The reference category was e-cigarettes. We repeated the regression for 
perceived risk of developing heart disease and oral cancer. 
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We also examined the demographic and behavioral variables listed in Table 4.1 as 
potential correlates of the composite perceived risk measure for e-cigarettes using bivariate 
linear regressions. We included variables with statistically significant bivariate relationships 
to perceived risk in a simultaneous multivariate linear regression model. 
Analyses were run in Stata Version 12. Frequencies are unweighted. Percentages and 
all other analyses used the “svy” command and post-stratification weights to adjust for the 
representativeness of the sample compared to the U.S. population and the sampling design, 
including the combination of probability and non-probability samples. We report 
standardized regression coefficients as betas (β). Statistical tests were two-tailed with a 
critical alpha of .05. 
 
Results 
Of current smokers (n=6,607) in our sample, most were non-Hispanic White (69%) 
(Table 4.1). About half were female (51%), had at least some college education (47%), and 
had an annual household income over $50,000 (45%). Half had tried e-cigarettes at least once 
in the past, and 21% currently used them. Only 6% had ever tried dissolvable tobacco 
products. Most respondents intended to quit smoking cigarettes in the next year (54%) or 
more than 1 year from now (15%). 
Comparison of E-Cigarettes to Cigarettes (Hypothesis 1) 
Participants perceived e-cigarettes as less likely to cause lung cancer (mean 
difference 1.17 between values for e-cigarettes and cigarettes, p<.001), heart disease (1.07, 
p<.001), and oral cancer (1.04, p<.001) compared to regular cigarettes (Figure 4.1). The 
belief that e-cigarettes were less harmful than regular cigarettes was robust. It persisted in in 
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each tested demographic subgroup, all p<.001: men (mean difference 1.09 between values 
for e-cigarettes and regular cigarettes), women (1.10), high school or less education (1.20), 
some college or more education (0.96), non-Hispanic Whites (1.06), non-Hispanic Blacks 
(1.56), non-Hispanics of other or multiple races (0.78), Hispanics (0.91), those with 
household incomes below $50,000 (1.14), and those with household incomes of $50,000 or 
more (1.03). It also persisted among smokers who plan to quit in the next year (1.25), 
smokers who plan to quit more than one year from now (1.05), smokers who do not plan to 
quit (0.86), ever users of e-cigarettes (1.06), and never users of e-cigarettes (1.09). 
Comparison of Alternative OTPs to Cigarettes (Hypothesis 2) 
Participants believed that smokeless tobacco was less likely to cause lung cancer than 
cigarettes (mean difference 0.51 between values for smokeless tobacco and cigarettes, 
p<.001), equally likely to cause heart disease (0.06, p=.13), and more likely to cause oral 
cancer (0.61, p<.001) (Figure 4.1). Similarly, compared to cigarettes, participants perceived 
snus as less likely to cause lung cancer (0.58, p<.001), equally likely to cause heart disease 
(0.07, p=.14), and more likely to cause oral cancer (0.58, p<.001). Participants also believed 
that dissolvable tobacco was less likely to cause lung cancer (0.54, p<.001) and more likely 
to cause oral cancer (0.27, p<.001) than cigarettes, but they believed that dissolvable tobacco 
was less likely to cause heart disease compared to regular cigarettes (0.17, p<.001). 
Comparisons Between E-Cigarettes and Alternative OTPs  
Smokers believed that they were more likely to develop lung cancer from using 
smokeless tobacco, snus, or dissolvable tobacco than from e-cigarettes (mean differences 
0.57, 0.58, and 0.74, respectively; all comparisons p<.001) (Figure 4.1, Table 4.2). They 
similarly perceived greater likelihood of developing heart disease from other non-
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combustible products than from e-cigarettes (mean differences 0.97 for smokeless tobacco, 
0.98 for snus, and 1.08 for dissolvable tobacco; all comparisons p<.001). Participants also 
believed that smokeless tobacco, snus, and dissolvable tobacco were more likely to cause 
oral cancer than e-cigarettes (mean differences 1.59, 1.58, and 1.44, respectively; all 
comparisons p<.001). 
Correlates of Perceived Risks of E-Cigarette Use 
Multivariate analysis of perceived risks of e-cigarette use found that women 
perceived themselves as more likely to develop health problems from using e-cigarettes 
(β=0.11, p<.01) than men (Table 4.3). Compared to non-Hispanic whites, non-Hispanic 
participants of other or multiple races believed themselves to be more at risk from using e-
cigarettes (β=0.08, p<.05), as did Hispanic participants (β=0.14, p<.01). Neither intention to 
quit smoking nor use of e-cigarettes was associated with perceptions of the health risks of e-
cigarettes.  
 
Discussion 
We aimed to understand smokers’ perceptions of the likelihood that tobacco products 
would cause them to develop lung cancer, oral cancer, and heart disease. Because 
respondents were smokers and the survey item about alternative products appeared directly 
after a similar item about regular cigarettes, we believe that smokers treated regular cigarettes 
as a benchmark for establishing risk. Their expressed beliefs about the other products 
reflected a comparison to regular cigarettes, although this comparison was not necessarily 
scientifically accurate. One of the key safety advantages of OTPs over cigarettes is the lack 
of combustion.140,141 If participants understood this distinction, they would have described all 
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four OTPs as consistently less harmful than regular cigarettes, but their views varied by 
product type and health problem. 
As hypothesized, smokers believed that e-cigarettes were less likely to cause health 
problems than regular cigarettes (Hypothesis 1). This response could reflect the process 
participants used to arrive at their judgments of health risks. Instead of careful reasoning, 
smokers may use mental shortcuts or heuristics related to perceived “goodness” or 
“badness,” a process known as the affect heuristic.148 Participants may have had a positive 
affective response to e-cigarettes, which have been branded as fashionable, new, and safe149 
compared to regular cigarettes, which are likely viewed as outmoded, old, and unhealthy. 
Exposure to pro-e-cigarette messages could drive these impressions. Two of the most 
common ways that current smokers report learning about e-cigarettes were e-cigarette users 
and advertisements on television, both of which likely tout the advantages of the 
product.132,150 Positive messages about e-cigarettes also appear regularly on YouTube151 and 
in online ads.135 In addition, Rogers’ diffusion of innovation theory suggests that smokers 
might hold this positive view because e-cigarettes are novel products and thus perceived to 
have relative advantages (including, potentially, healthfulness) over the product they are 
replacing, i.e., regular cigarettes.93 Although snus and dissolvable tobacco are also novel 
products, they may be too different in form to be considered a replacement for cigarettes.  
Although smokers consistently described e-cigarettes as less harmful than regular 
cigarettes, there was some variation in individuals’ beliefs about e-cigarettes’ healthfulness. 
Women believed that e-cigarettes were more likely to cause health problems than did men. 
Women often, although not always,152 perceive themselves to be at higher risk of developing 
health problems than men,153 and that includes smoking-related cancer.154 Because boys are 
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socialized to be strong, take risks, and avoid seeking help, men—particularly those with 
stronger masculine identity—are more likely than women to see themselves as 
invulnerable.153 Additionally, women may feel at increased risk because they are often more 
involved with family life than men, so they could be exposed to more cases of cancer among 
family members and thus believe cancer to be more common.155 Non-Hispanic Whites 
perceived themselves at lower risk of experiencing health problems from e-cigarettes than 
did some other racial and ethnic groups. These differences could reflect participants’ 
understanding that racial and ethnic minorities are more likely to die from some tobacco-
related illnesses than non-Hispanic Whites.156  
Past use of e-cigarettes and intention to quit smoking were not related to beliefs about 
the riskiness of e-cigarettes. These findings may reflect a general lack of variability in 
perceptions of the likelihood that e-cigarettes cause health problems and a general positive 
affective response to e-cigarettes.148 Even though there was no cross-sectional relationship 
between risk beliefs and use of e-cigarettes, we cannot conclude that these variables are 
unrelated. Only longitudinal or experimental studies can confirm the behavior motivation 
hypothesis, i.e., that e-cigarette risk perceptions cause a change in e-cigarette use.157  
As anticipated in Hypothesis 2, participants believed that snus and dissolvable and 
smokeless tobacco were more likely to cause oral cancer than cigarettes, although this is not 
objectively true.141 This difference likely relates to the mode of nicotine delivery and the 
physical act of use. In a 2010 focus group study, young adults expressed particular concern 
about snus and dissolvable tobacco because those products come in direct contact with the 
mouth, and thus they perceived them to be likely to cause oral cancer and gastrointestinal 
disease.89 Traditional smokeless tobacco is also placed directly in the mouth, so it might be 
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perceived similarly. Indeed, people often overestimate the harm of smokeless tobacco,115 an 
error that is common even among tobacco control professionals.158  
In line with the belief that mode of nicotine delivery affects health risk, smokers 
viewed regular cigarettes as more likely to cause lung cancer than oral cancer. Respondents 
may have perceived that cigarettes’ primary mode of contact, unlike snus, dissolvable 
tobacco, or smokeless tobacco, is inhaled smoke. That smokers viewed smokeless tobacco, 
snus, and regular cigarettes as equally likely to cause heart disease is consistent with this 
hypothesis; mode of tobacco administration has no clear connection to the heart. The 
difference between dissolvable tobacco and cigarettes with respect to heart disease appears to 
be an artifact of that group having slightly higher ratings of the likelihood that cigarettes 
cause heart disease. 
The finding from the exploratory analysis that smokers in our study perceived e-
cigarettes to be less harmful than snus, dissolvable tobacco, and smokeless tobacco is 
consistent with the literature. A recent survey of university students reported similar findings, 
although the report did not explicitly test these comparisons.159 The perceived differences 
between e-cigarettes and the alternative OTPs may reflect exposure to positive messages in 
e-cigarette marketing. Future studies could explore that hypothesis by comparing the amount 
and content of advertising for each product. 
All studies of perceived health risks, including this one, include an important 
limitation with respect to measurement. Perceptions of risk can vary by how one asks the 
question,126,160 and there are many ways to ask about risk (e.g., relative versus absolute, 
numeric vs. semantic response scales). For example, one recent study found that perceptions 
of harm caused by snus versus cigarettes were not equivalent when participants were asked 
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directly (i.e., one question asking for an explicit comparison) or indirectly (i.e., one question 
per product, then comparing ratings).161 Thus the results of the present study may have been 
influenced by the measure of risk. Further, smokers may be particularly bad at judging risk, 
regardless of question type, because they engage in defensive processing and thus discount 
their own risk.107 Indeed, few smokers believed that they were “very likely” or “extremely 
likely” to experience any of the health conditions for any of the products.  
Additional limitations include that this study only asked about cancer and heart 
disease, not other conditions like emphysema, and only used single-item measures of risk for 
each illness. The combination of probability and non-probability samples is also a limitation, 
although the large probability sample helped us properly weight the non-probability sample. 
Finally, the cross-sectional design prevents us from establishing whether risk beliefs cause 
changes in behavior.157 In spite of these limitations, the data present a clear picture that 
smokers perceive the health risks of e-cigarettes to be lower than both traditional and 
alternative tobacco products. 
The widespread belief that e-cigarettes are less harmful than other products may be 
driving their rise in popularity. Should that be the case, our findings suggest that use of 
alternative OTPs, including novel ones like snus and dissolvable tobacco, are unlikely to 
increase in the same manner as e-cigarettes. Although using non-combustible tobacco is less 
risky than cigarette smoking, few data exist on the short- and long-term health effects of e-
cigarettes in particular. Additional research is needed to quantify both the absolute risk of 
using e-cigarettes, as well as the risk of using e-cigarettes relative to that of smoking 
cigarettes. Future research should also investigate the impact of exposure to e-cigarette 
advertising and other media on beliefs about e-cigarettes’ harm, how beliefs about e-
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cigarettes’ harm change over time, and whether those beliefs affect smokers’ trajectories of 
e-cigarette and regular cigarette use. Such research could help the public health community 
identify and deliver appropriate messages about e-cigarettes’ safety.  
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Table 4.1. Sample Characteristics (n=6,607 current smokers) 
 
Characteristic n Weighted % 
Respondent   
Gender   
Male 2,654 48.8 
Female 3,953 51.2 
Age, mean (SD)  44.2 (15.2) 
Education   
Less than high school 365 9.9 
High school 1,777 42.9 
Some college 2,976 34.0 
Bachelor’s degree or higher 1,489 13.2 
Race/ethnicity   
Non-Hispanic White 5,179 68.7 
Non-Hispanic Black 535 12.6 
Non-Hispanic, Other/multiple races 412 6.3 
Hispanic 481 12.4 
Employment   
Working 3,380 53.6 
Not working: laid off or looking for work 855 14.2 
Not working: retired, disabled, or other 2,372 32.2 
Intention to quit smoking   
In the next year 3,683 53.7 
More than 1 year from now 918 15.0 
Do not plan to quit 2,006 31.3 
E-cigarette awareness and use   
Not aware 296 5.1 
Aware but never tried 2,969 44.7 
Former user 1,876 29.4 
Current user 1,466 20.9 
Dissolvable tobacco awareness and use   
Not aware 4,667 71.2 
Aware but never used 1,493 22.5 
Have used 447 6.3 
Household   
Region    
Midwest 1,657 24.3 
Northeast 1,123 17.4 
South 2,305 39.9 
West 1,522 18.4 
Household income   
Less than $25,000 2,038 29.2 
$25,000 - $49,999 1,983 26.4 
$50,000 - $74,999 1,313 19.1 
$75,000 - $99,999 687 14.9 
$100,000 or more 586 10.5 
 
Note. Percentages are weighted, and n’s are unweighted.  
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Table 4.2. Comparison of Smokers’ Perceived Likelihood of Health Problem by Type of 
Product (n=6,607) 
 
 Mean (SD) β 
Lung cancer   
E-cigarettes 1.89 (1.03)  
Smokeless tobacco 2.46 (1.27) 0.19*** 
Snus 2.47 (1.30) 0.20*** 
Dissolvable tobacco 2.63 (1.33) 0.25*** 
Heart disease   
E-cigarettes 1.90 (1.04)  
Smokeless tobacco 2.87 (1.26) 0.32*** 
Snus 2.88 (1.27) 0.33*** 
Dissolvable tobacco 2.98 (1.27) 0.35*** 
Oral cancer   
E-cigarettes 1.89 (1.03)  
Smokeless tobacco 3.48 (1.22) 0.50*** 
Snus 3.47 (1.22) 0.50*** 
Dissolvable tobacco 3.33 (1.26) 0.45*** 
 
Note. Higher mean scores indicate higher perceived likelihood of a health problem (1= not at 
all likely – 5 = extremely likely). 
***p<.001. 
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Table 4.3. Correlates of Perceived Likelihood that E-Cigarettes Cause Health Problems 
(n=1,669) 
 
Characteristic Mean (SD) Bivariate β Multivariate β 
Respondent     
Gender    
Male (Ref) 1.80 (0.86)   
 Female 2.00 (1.22) 0.10* 0.11** 
Age  -0.07  
Education    
Less than high school (Ref) 1.96 (0.85)   
High school 1.85 (0.76) -0.05  
Some college 1.93 (1.21) -0.01  
Bachelor’s degree or higher 1.93 (1.49) -0.01  
Race/ethnicity    
Non-Hispanic White (Ref) 1.83 (1.08)   
Non-Hispanic Black 1.83 (0.85) -0.00 0.00 
Non-Hispanic, Other/multiple  2.15 (1.12) 0.07* 0.08* 
Hispanic 2.27 (0.85) 0.13** 0.14** 
Employment    
Working (Ref) 1.94 (0.97)   
Not working: laid off or looking for work 1.93 (1.16) -0.00  
Not working: retired, disabled, or other 1.82 (1.08) -0.06  
Intention to quit smoking    
In the next year (Ref) 1.81 (0.97)   
More than 1 year from now 1.97 (1.12) -0.06  
Do not plan to quit 1.79 (0.91) -0.08  
E-cigarette awareness and use    
Not aware or never used (Ref) 1.86 (0.99)   
Former user 1.89 (0.99) 0.01  
Current user 1.99 (1.22) 0.05  
Household    
Region     
Midwest (Ref) 1.90 (1.03)   
Northeast 1.81 (0.94) -0.04  
South 1.88 (0.97) -0.01  
West 2.03 (1.26) 0.05  
Household income    
Less than $25,000 (Ref) 1.89 (1.16)   
$25,000 - $49,999 1.97 (1.13) 0.04  
$50,000 - $74,999 1.89 (0.96) 0.00  
$75,000 - $99,999 1.72 (0.80) -0.06  
$100,000 or more 2.00 (1.00) 0.04  
 
Note. Multivariate model contained correlates significant (p<.01) in bivariate models.  
*p<.05, **p<.01, ***p<.001. 
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Figure 4.1. Perceived health risks of tobacco products. Error bars show standard errors. 
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CHAPTER 5: EFFECTS OF ADVERTISEMENTS ON SMOKERS’ INTEREST IN 
TRYING E-CIGARETTES: THE ROLES OF PRODUCT COMPARISON AND 
VISUAL CUES 
Introduction 
Electronic cigarettes, also called e-cigarettes or electronic nicotine delivery systems, 
are battery-powered devices that heat cartridges, which typically contain nicotine and 
humectants, to create a vapor that the user inhales. E-cigarettes are controversial. The 
scientific community is concerned about safety,2,3,142 the product’s use as a “gateway” to 
other tobacco products,6 and the possibility of renormalizing smoking.162 At the same time, e-
cigarettes are a non-combustible product that could meet some of the needs of nicotine-
addicted smokers and thus hold the potential to be a valuable harm reduction tool for 
smokers who switch.143 Many e-cigarette users also claim that e-cigarettes helped them quit 
smoking.44,49 Longitudinal studies and large surveys are inconsistent in supporting this 
claim.68,163,164 The one randomized controlled trial that compared e-cigarettes to another 
nicotine replacement therapy did not find a difference between cessation rates for e-cigarettes 
versus the nicotine patch.130 
Despite the controversy, e-cigarettes are increasingly popular. Use is particularly high 
among smokers,58,59,132 with 32% of smokers in 2012 and 50% of smokers in 2013 reporting 
having ever tried e-cigarettes.132,137 The glut of e-cigarette advertising could be contributing 
to e-cigarettes’ rise in popularity. Greater exposure to cigarette advertising predicts greater 
likelihood of smoking initiation.165,166 By extension, exposure to e-cigarette advertising may 
prompt people to start using e-cigarettes. Smokers appear to respond positively to such ads. 
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In a recent study, two-thirds of smokers who watched a television ad for Blu e-cigarettes 
indicated interest in trying e-cigarettes after watching the ad, although this study did not use 
an experimental protocol or measure interest prior to exposure.167 While we cannot draw a 
causal inference, rates of use of e-cigarettes have risen58,94,132 in tandem with increases in e-
cigarette advertising.124,168,169  
Television, radio, and print ads and other forms of e-cigarette marketing aimed at 
smokers often compare e-cigarettes with regular cigarettes.124,149,168 Ads describe e-cigarettes 
as newer, healthier, cheaper, and easier to use in smoke-free situations, all reasons that e-
cigarette users claim motivate their use.94,132 Advertisers also promote e-cigarettes as a 
cessation tool, although they often use indirect methods like affiliate marketing135,151 to avoid 
violating a 2010 U.S. district court decision that blocked such claims.170 Some ads also 
highlight how e-cigarette use mimics the positive aspects of smoking regular cigarettes, i.e., 
the social experience or satisfaction. 135,151 
Smokers’ responses to different ads may depend on how they view the comparison 
between the novel or innovative product (i.e., e-cigarettes) and the traditional one (i.e., 
regular cigarettes). Unique features of new nicotine products might be attractive in ways that 
will encourage use.171 Commentary and theory regarding the diffusion of innovation is useful 
in this regard, as it suggests that adoption of a new technology is faster when the innovation 
embodies certain key characteristics.93 First, innovations that spread quickly have a relative 
advantage over the object they are replacing (e.g., e-cigarettes cost less than cigarettes). 
Second, popular innovations are compatible with the values, experiences, and needs of the 
adopter (e.g., using e-cigarettes feels the same as smoking).  
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Our study sought to better understand the potential for advertising to facilitate 
diffusion of e-cigarettes to current cigarette smokers. We conducted an experiment testing 
advertising messages that focus on differences between e-cigarettes and regular cigarettes 
(i.e., relative advantage) and similarities of the two products (i.e., compatibility). The specific 
messages we chose to include in these ads are typical messages found in e-cigarette 
advertising, as shown in recent content reviews.124,168,169 Based on our observation that many 
e-cigarette ads depicted a person using an e-cigarette, we also aimed to understand why such 
ads might be particularly persuasive. We chose three images (a woman using an e-cigarette, a 
man not using an e-cigarette, and an e-cigarette kit) to determine which feature of the ad (that 
it showed a person, the product, or a person interacting with the product) produced the 
greatest interest.   
We predicted that ads emphasizing the differences (i.e., relative advantages) between 
e-cigarettes and regular cigarettes would elicit more interest in trying e-cigarettes than 
control ads, because many smokers view cigarettes as unhealthy,172 are aware of the 
substantial stigma attached to smoking,127,128 and want to quit.173. We expected less benefit of 
ads emphasizing their similarities (i.e., compatibility), because smoking is a stigmatized 
activity even among smokers.128 We also predicted that smokers would be more interested in 
trying e-cigarettes when shown an ad depicting a person using an e-cigarette compared to ads 
with other images. Images of smoking cause cravings among smokers,174,175 so seeing 
someone use a similar-looking product could elicit desire to use the product.  
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Methods 
Sample 
In March 2013, 17,522 U.S. adult (age 18 or older) smokers and non-smokers 
completed an online survey as part of the Tobacco Control in a Rapidly Changing Media 
Environment study. Seventy-five percent of respondents came from KnowledgePanel, a 
nationally representative online survey panel constructed using random-digit dialing 
supplemented by address-based sampling to account for cell phone–only households. A 
convenience sample of adults who responded to online ads comprised the remaining 25%; 
the survey company screened their names and addresses, removed duplicates, and quota 
matched to the probability sample based on demographics and tobacco use characteristics. Of 
the 34,097 KnowledgePanel members sampled, 61% completed the screening, and 97% of 
those who were eligible completed the online survey. Response rate data for the convenience 
samples are not available because there is no known sampling frame. For this study, we 
report data from current smokers (those who reported smoking every day or some days) who 
had never tried e-cigarettes (n=3,253). All participants provided consent online before 
beginning the survey. Institutional review boards at the National Cancer Institute and the 
University of Illinois at Chicago approved the study.  
Procedures 
We randomly assigned participants to one of 9 conditions in a 3 (image in ad) X 3 
(type of comparison) between-subjects factorial experiment. An advertising agency designed 
the ads (Figure 5.1) with a mock e-cigarette brand, “Evermist e-cigs.” The ad image showed 
a person using an e-cigarette (a woman using an e-cigarette with a red glowing tip), a 
rechargeable e-cigarette kit, or no e-cigarette (a man looking at a laptop computer screen). 
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Each ad had one of three headlines, which indicated a comparison type (difference, 
similarity, or neither (i.e., control)). The difference ads had the headline, “Better than a 
cigarette” accompanied by one of four ad messages (costs less, use anywhere, healthier, and 
helps to quit smoking) that emphasized the differences between the products. The similarity 
ads had the headline, “Just like a cigarette” accompanied by one of three ad messages (feels 
the same as smoking, relieves your cravings, and still smoke with friends) that emphasized 
the similarities between e-cigarettes and regular cigarettes. The control ads (no comparison) 
had the headline, “E-cigarettes” accompanied by a message (great to use) that did not 
emphasize differences similarities or differences.  
Measures 
While viewing the ad, participants responded to the item, “How much does seeing 
this ad make you want to try e-cigarettes?” using a 5-point scale (“not at all” (coded as 1), “a 
little bit” (2), “a moderate amount” (3), “quite a bit” (4), and “a great deal” (5)). 
Data Analysis 
To check whether random assignment created demographically equivalent groups by 
comparison type (similarity, difference, and control), we used chi square tests for categorical 
demographic variables (gender, education, race/ethnicity, employment status, and income) 
and linear regression for the continuous demographic variable (age). We repeated these tests 
for ad message and for the other experimental manipulation, ad image.  
We examined the effects of the experimental manipulations on interest in trying e-
cigarettes using a 3 X 3 ANOVA. The factors were comparison type and ad image. Because 
the interaction was not statistically significant (p=.20), we repeated the ANOVA model 
without the interaction term. We used a Bonferroni correction to adjust for multiple 
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comparisons. We also used ANOVA to confirm that there was no interaction between the 
experimental manipulations and the sampling method (i.e., whether the experimental findings 
differed for respondents recruited through convenience versus probability sampling) (p>.05 
for both interactions). For descriptive purposes, we conducted a linear regression to 
determine if interest in trying e-cigarettes varied by the specific ad message (relieves 
cravings, costs less, etc.), using the control message (great to use) as the reference category. 
We also conducted an ANOVA testing a possible interaction between specific ad message 
and image on interest in trying e-cigarettes. The interaction was not significant (p=.36), so 
we do not report it here. 
Data are not weighted because of the experimental design. Analyses with Stata 
Version 12 used two-tailed statistical tests and a critical α of 0.025 for the ANOVA and .05 
for the linear regression.  
 
Results 
The majority of participants were female (59%) and non-Hispanic White (77%) and 
had at least some college education (67%) and an annual household income less than $50,000 
(62%) (Table 5.1). About half (48%) were currently working, and the mean age was 50 years 
(standard deviation 15 years). Fifty-one percent intended to quit smoking in the next year and 
14% more than one year from now, while 35% did not intend to quit smoking. Demographic 
characteristics of participants were equivalent across experimental conditions (all p>.05, 
Table 5.2). 
Interest in trying e-cigarettes varied by comparison type (F (2, 3248) = 3.94, p<.025). 
One type of comparison ad generated effects on viewer interest: Ads that emphasized the 
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differences between cigarettes and e-cigarettes (mean interest 2.08) created more interest 
than control ads (mean 1.89, p<.05) (Table 5.3; Figure 5.2). The other type of comparison ad 
did not generate such differences: Smokers reported similar interest in trying e-cigarettes 
after viewing control ads and ads that emphasized similarity (mean 2.04, p=.06).  
As for the specific comparison claims, advertisements elicited greater interest in 
trying e-cigarettes when they had messages stating that e-cigarettes differed from regular 
cigarettes because they were healthier than cigarettes (mean 2.12, p<.01), were less 
expensive than cigarettes (2.09, p<.05), or were helpful to quit smoking (2.06, p<.05) as 
compared to the control message (1.89) (Table 5.3). Interest in trying e-cigarettes was also 
higher when the ad stated that e-cigarettes were similar to cigarettes because they could be 
used with friends (2.09, p<.05) compared to an advertisement with a control message. The 
other three experimental messages elicited equivalent interest as the control message.  
Interest in trying e-cigarettes also varied by ad image (F (2, 3248) = 6.95, p<.01). Ads 
showing a person using an e-cigarette (mean 2.15) created more interest than ads not 
showing an e-cigarette (mean 1.98, p<.01), but there was no difference between ads showing 
an e-cigarette kit (mean 2.00) and ads not showing an e-cigarette (p>.99) (Figure 5.3).  
 
Discussion 
Smokers expressed moderate interest in trying e-cigarettes after viewing the 
advertisements, but their level of interest varied as a function of comparison type, message, 
and image. The type of promotional strategy used made a significant difference as to whether 
an e-cigarette ad generated interest among smokers. The depiction of people actually using 
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the new product and comparisons that emphasized differences between e-cigarettes and 
regular cigarettes appeared to have important effects.  
Consistent with our prediction, interest was higher among respondents who viewed 
difference-focused ads compared to the control ad. As a relatively new entry to the U.S 
market, e-cigarettes are innovative tobacco products. Although both relative advantage and 
compatibility enhance the likelihood that an innovation will be adopted,93 the old product in 
this instance, namely regular cigarettes, is stigmatized and unattractive.127,128 Indeed, most 
smokers want to quit.173 Thus the innovative tobacco product was more attractive when 
framed as different from the original, while similarity messages had little or no impact. 
The specific ad messages associated with the greatest amount of interest described e-
cigarettes’ healthfulness, cost, use as a quit tool, and the social experience of use. That 
responses to messages about health and cessation were more positive than responses to other 
messages is consistent with the literature; e-cigarette users frequently report these as reasons 
for use.94 In prior survey research, e-cigarettes’ cost relative to cigarettes appears to motivate 
trying the product, although some users find the product to be more expensive than 
anticipated and may even discontinue use for this reason.50,51,94 Although the social 
experience of using with friends is not as frequently mentioned by current e-cigarette users, it 
may be that this factor created some of their initial interest in trying the product, as was 
found here, but did not impact their continued use.  
That the message “relieves your cravings” was unrelated to interest is not surprising 
as research on smokers’ subjective and objective experiences show large variability in e-
cigarettes’ ability to deliver a satisfactory amount of nicotine.44,54,79,88 Smokers may be aware 
of this issue if they have discussed e-cigarettes with other smokers who have tried them. 
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Indeed, smokers say that e-cigarette users are their most frequent source of information about 
the product.150 The message that e-cigarettes can be used anywhere was also not particularly 
attractive to smokers. This result could reflect a social desirability bias. Smokers might not 
want to admit that they wish to skirt popular restrictions on smoking.176,177 It could also 
reflect that smokers did not believe the e-cigarettes could indeed be used in this way because 
of new laws or restrictions or complaints from other people.178,179 Unlike the claim “use with 
friends,” which smokers may have actually experienced in their personal lives, the claim “use 
anywhere” (emphasis ours) is something that they likely know is not objectively true. 
The ads that depicted a woman using an e-cigarette were more popular than the ads 
showing an e-cigarette kit or a man with a laptop. Although we cannot rule out that the 
increased interest was because of the attractive woman, we suspect that it reflects a type of 
cross-cue reactivity. As described in the cue reactivity literature, smokers experience 
cravings when they see images of smoking.174,175 In this case, viewing the image of e-
cigarette use may also have served as a subliminal cue for craving, which thus increased 
interest in trying a cigarette-like product. Smokers did not respond this way to the image of 
the e-cigarette kit not in use, possibly because this image showed a battery charger and tray 
of cartridges, which make the e-cigarette look less like a regular cigarette. Social learning 
theory180 also suggests that seeing someone use an e-cigarette models the behavior, which 
could motive interest and, later, use. 
Our findings have implications for both regulation and public health messaging. If 
ongoing research finds that e-cigarette use causes health problems or deters significant 
numbers of smokers from quitting, the public health community will need to discourage e-
cigarette use among adult smokers. Future public health campaigns likely would need to use 
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materials that do not show the product being used, because this appears to be related to 
increased interest. One editorial recently suggested banning television ads that show smoking 
behavior, regardless of what product is being smoked.181 
The potential effects of advertising on e-cigarette use is concerning. Although e-
cigarettes produce fewer harmful emissions than regular cigarettes,108 they are not harm-free. 
Moreover, if non-smokers or youth begin using e-cigarettes or if smokers use e-cigarettes in 
lieu of quitting, there may be a net harm at the population level even if there is a benefit for 
an individual smoker. Brazil and other countries have banned e-cigarette advertising and the 
European Union will follow suit beginning in mid-2016.182,183 If specific claims are unproven 
(e.g, e-cigarettes help smokers quit or e-cigarettes have zero toxins), they should not be 
allowed in advertising even if e-cigarette advertising as a whole is not banned.  
Regulations restricting e-cigarette advertising features that appeal to youth are also 
critical, particularly given the history of marketing regular cigarettes. Camel’s Old Joe 
campaign successfully promoted that brand to youth in the U.S.,184 and in 1991, the same 
proportion (over 90%) of 6-year-old children recognized the Old Joe logo as recognized the 
Disney logo.185 The 1997 Master Settlement Agreement prevented tobacco companies from 
using cartoon characters or otherwise targeting youth under age 18 in their advertising. We 
do not yet know what e-cigarette advertising features or logos will be compelling to young 
people or the extent to which those features will motivate e-cigarette experimentation. 
Should future studies like this one find that certain ad design features (e.g., cartoons) appeal 
to youth, regulations should limit those features. Research in this area is particularly 
important given the potentially strong appeal of candy- and fruit-flavored e-cigarettes to 
children. 
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Limitations to this study include the use of a psychosocial but not behavioral outcome 
measure. In addition, the majority of experiment participants were recruited through online 
convenience sampling, which limits the generalizability of the findings to the entire U.S. 
adult population, although we confirmed that our findings did not differ by sampling method. 
The experiment elicited relatively small effects; however, given that there were 42 million 
adult smokers in the U.S. in 2012,186 small effects could still result in meaningful real-world 
changes.187  
We chose to design new ads instead of modifying existing ads because we sought to 
exert greater experimental control than existing ads would permit. By working with an ad 
agency to design new ads, we were able to maintain the maximum amount of control when 
varying characteristics (e.g., the ability to change the image without impacting other aspects 
of the layout). However, these new ads may not have matched the “feel” or effectiveness of 
real-world ads. Future studies might incorporate real ads to increase the external validity of 
findings and also use ads with several images, including males using e-cigarettes. In our 
study, we could not conclude whether smokers were more interested in trying e-cigarettes 
when shown an image of woman using an e-cigarette because they thought the specific 
woman depicted was attractive or because she was engaging in a smoking-like behavior. We 
also did not explore non-smokers’ responses to the ads and did not include a “no ad” 
condition to establish interest in trying e-cigarettes in the absence of an advertisement.  
Finally, one critique of much work in research on communication is that intention to 
perform a behavior does not necessarily lead to that behavior. Although the intention-
behavior gap is well documented in many areas, intentions remain a strong predictor of 
behavior.188 Of course, we believe that this gap should not deter regulatory authorities from 
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instituting appropriate restrictions on e-cigarette advertising. Despite these limitations, the 
data are compelling and useful for future investigations of new e-cigarette marketing. The 
randomized design and large national sample are key strengths of the study. 
E-cigarettes are a big—and rapidly growing—business. In 2013, sales of e-cigarettes 
were nearly $2 billion, and sales are likely to rise to $10 billion by 2017.189 Multinational 
tobacco companies are entering the e-cigarette market by buying existing companies or 
developing their own products. The involvement of these companies will likely increase the 
amount, reach, and sophistication of e-cigarette advertising,124,149,168 and recent research 
suggests that exposure to e-cigarette advertising is associated with interest in trying the 
product.167,190 With the new evidence presented in this paper, it is clear that specific types of 
messages used to promote e-cigarettes are more effective in soliciting interest among current 
smokers who have yet to try e-cigarettes. Armed with such evidence, public health 
professionals can monitor e-cigarette marketing across a variety of channels and consider 
what claims and imagery regulations should address.  
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Table 5.1. Sample Characteristics (n=3,253) 
 
 n % 
Respondent   
Gender   
Male 1,347 41.4 
Female 1,906 58.6 
Age, mean (SD)  49.6 (14.7) 
Education   
Less than high school 174 5.4 
High school 897 27.6 
Some college 1,363 41.9 
Bachelor’s degree or higher 819 25.2 
Intention to quit smoking   
In the next year 1,668 51.3 
More than 1 year from now 440 13.5 
Do not plan to quit 1,145 35.2 
Race/ethnicity   
Non-Hispanic White 2,506 77.0 
Non-Hispanic Black 315 9.7 
Non-Hispanic, other or multiple races 199 6.1 
Hispanic 233 7.2 
Employment   
Working 1,563 48.1 
Not working: laid off or looking for 
work 
393 12.1 
Not working: retired, disabled, or other 1,297 39.9 
Household   
Household income   
Less than $25,000 1,035 31.8 
$25,000 - $49,999 982 30.2 
$50,000 - $74,999 618 19.0 
$75,000 - $99,999 341 10.5 
$100,000 or more 277 8.5 
 Table 5.2. Respondent Characteristics by Experimental Condition 
 
Condition (n in condition) Diff & 
No EC 
(559) 
Diff & 
EC Kit 
(549) 
Diff & 
EC User 
(557) 
Simil & 
No EC 
(395) 
Simil & 
EC Kit 
(392) 
Simil & 
EC User 
(392) 
Control 
& No EC 
(137) 
Control 
& EC Kit 
(145) 
Control 
& EC 
User 
(127) 
Respondent  n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Gender          
Male 244 
(43.7%) 
231 
(42.1%) 
212 
(38.1%) 
160 
(40.5%) 
167 
(42.6%) 
161 
(41.1%) 
58 
(42.3%) 
57 
(39.3%) 
57 
(44.9%) 
Female 315 
(56.4%) 
318 
(57.9%) 
345 
(61.9%) 
235 
(59.5%) 
225 
(27.4%) 
231 
(58.9%) 
79 
(57.7%) 
88 
(60.7%) 
70 
(55.1%) 
Age, mean (SD) 49.3 
(14.8) 
49.9 
(15.5) 
49.5 
(15.5) 
48.9 
(15.2) 
50.1 
(14.6) 
49.8 
(14.9) 
50.1 
(13.9) 
49.3 
(14.9) 
50.2 
(15.4) 
Education          
Less than high school 32 
(5.7%) 
26 
(4.7%) 
34 
(6.1%) 
22 
(5.6%) 
19 
(4.9%) 
20 
(5.1%) 
9 (6.6%) 8 (5.5%) 4 (3.2%) 
High school 147 
(26.3%) 
150 
(27.3%) 
161 
(28.9%) 
114 
(28.9%) 
105 
26.8%) 
104 
(26.5%) 
30 
(21.9% 
48 
(33.1%) 
38 
(29.9%) 
Some college 233 
(41.7%) 
243 
(44.3%) 
224 
(40.2%) 
165 
(41.8%) 
181 
(46.2%) 
161 
(41.1%) 
57 
(41.6%) 
56 
(38.6%) 
43 
(33.9%) 
Bachelor’s degree or 
higher 
147 
(26.3%) 
130 
(23.7%) 
138 
(24.8%) 
94 
(23.8%) 
87 
(22.2%) 
107 
(27.3%) 
41 
(29.9%) 
33 
(22.8%) 
42 
(33.1%) 
Intention to quit smoking          
In the next year 278 
(49.7%) 
295 
(53.7% 
273 
(49.0%) 
212 
(53.7%) 
199 
(50.8%) 
197 
(50.3%) 
69 
(50.4%) 
79 
(54.5%) 
66 
(52.0%) 
More than 1 year from 
now 
77 
(13.8%) 
75 
(13.7%) 
68 
(12.2%) 
54 
(13.7%) 
52 
(13.3%) 
51 
(13.0%) 
22 
(16.1%) 
23 
(15.9%) 
18 
(14.2%) 
Do not plan to quit 204 
(36.5%) 
179 
(32.6%) 
216 
(38.8%) 
129 
(32.7%) 
141 
(36.0%) 
144 
(36.7%) 
46 
(33.6%) 
43 
(29.7%) 
43 
(33.9%) 
Race/ethnicity          
Non-Hispanic White 447 408 421 302 304 301 107 110 106 
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 (80.0) (74.3%) (75.6%) (76.5%) (77.6%)  (76.8%) (78.1%) (75.9%) (83.5%) 
Non-Hispanic Black 38 
(6.8%) 
63 
(11.5%) 
59 
(10.6%) 
39 
(9.9%) 
40 
(10.2%) 
40 
(10.2%) 
13 
(9.5%) 
13 
(9.0%) 
10 
(7.9%) 
Non-Hispanic, other or 
multiple races 
29 
(5.2%) 
38 
(6.9%) 
31 
(5.6%) 
29 
(7.3%) 
25 
(6.4%) 
25 
(6.4%) 
9 (6.6%) 9 (6.2%) 4 (3.2%) 
Hispanic 45 
(8.1%) 
40 
(7.3%) 
46 
(8.3%) 
25 
(6.3%) 
23 
(5.9%) 
26 
(6.6%) 
8 (5.8%) 13 
(9.0%) 
7 (5.5%) 
Employment          
Working 277 
(49.6%) 
263 
(47.9%) 
284 
(51.0%) 
185 
(46.8%) 
177 
(45.2%) 
171 
(43.6%) 
70 
(51.1%) 
77 
(53.1%) 
59 
(46.5%) 
Not working: laid off or 
looking for work 
61 
(10.9%) 
68 
(12.4%) 
60 
(10.8%) 
50 
(12.7%) 
52 
(13.3%) 
52 
(13.3%) 
14 
(10.2%) 
19 
(33.1%) 
17 
(13.4%) 
Not working: retired, 
disabled, or other 
221 
(39.5%) 
218 
(39.7%) 
213 
(38.2%) 
160 
(40.5%) 
163 
(41.6%) 
169 
(43.1%) 
53 
(38.7%) 
49 
(33.8%) 
51 
(40.2%) 
Household          
Household income          
Less than $25,000 168 
(30.1%) 
180 
(32.8%) 
183 
(32.9%) 
115 
(29.1%) 
137 
(35.0%) 
127 
(32.4%) 
36 
(26.3%) 
45 
(31.3%) 
44 
(34.7%) 
$25,000 - $49,999 163 
(29.2%) 
168 
(30.6%) 
158 
(28.4%) 
136 
(34.4%) 
118 
(30.1%) 
127 
(32.4%) 
38 
(27.7%) 
41 
(28.3%) 
33 
(26.0%) 
$50,000 - $74,999 113 
(20.2%) 
115 
(21.0%) 
113 
(20.3%) 
69 
(17.5%) 
60 
(15.4%) 
66 
(16.8%) 
28 
(20.4%) 
34 
(23.5%) 
20 
(15.8%) 
$75,000 - $99,999 69 
(12.3%) 
47 
(8.6%) 
50 
(9.0%) 
36 
(9.1%) 
47 
(12.0%) 
41 
(10.%) 
20 
(14.6%) 
15 
(10.3%) 
16 
(12.6%) 
$100,000 or more 46 
(8.2%) 
39 
(7.1%) 
53 
(9.5%) 
39 
(9.9%) 
30 
(7.7%) 
31 
(7.9%) 
15 
(11.0%) 
10 
(6.9%) 
14 
(11.0%) 
 
Note. Diff = difference, Sim = similarity, No EC = no electronic cigarette, EC kit = e-cigarette kit, EC user = woman using e-cigarette. 
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Table 5.3. Interest in Trying E-Cigarettes, By Ad Characteristics 
 
Comparison 
type  
Ad headline Mean (SD) Ad message Mean (SD) 
Control  E-Cigarettes 1.89 (1.10)   
   Great to use 1.89 (1.10) 
Similarity  Just like a 
cigarette 
2.04 (1.17)   
   Feels like 
smoking 
1.99 (1.14) 
   Relieves 
cravings  
2.05 (1.14) 
   Use with 
friends 
2.09 (1.23)* 
Difference  Better than a 
cigarette 
2.08 (1.19)**   
   Use anywhere 2.04 (1.22) 
   Helps you quit 2.06 (1.12)* 
   Costs less 2.09 (1.20)** 
   Healthier 2.12 (1.23)** 
 
Note. Higher means indicate greater interest in trying e-cigarettes (1= not at all – 5 = a great 
deal).  
Comparison to control headline/message *p<.05, **p<.01.  
 
 Figure 5.1. Four of twenty-four advertisements used in the experiment. 
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Figure 5.2. Effect of comparison type on interest in trying e-cigarettes. Error bars show 
standard errors. 
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Figure 5.3. Effect of advertisement image on interest in trying e-cigarettes. Error bars show 
standard errors. 
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CHAPTER 6: DISCUSSION 
Electronic Cigarettes and Diffusion of Innovation  
The three manuscripts comprising this dissertation are united by a common 
theoretical model, diffusion of innovation (DOI).93 Rogers’ DOI model describes how an 
innovative technology spreads in a population through five stages: knowledge (an individual 
learns of the innovation and how it functions), persuasion (the individual forms an attitude), 
decision (the individual chooses to adopt or reject the innovation), implementation (the 
individual begins to use it), and confirmation (the individual seeks reinforcement of or 
decides to reject the previous choice). 
E-cigarettes as an Innovation 
A technology does not necessarily need to be new to be considered an innovation. 
Although e-cigarettes have been available in the United States since 2006, the content of 
media coverage and advertising123,124,149 and the trends in awareness and use94,132 suggest that 
the public perceives them as new. Indeed, e-cigarettes embody the hallmarks of an innovative 
technology, particularly from the point of view of their primary consumers, current and 
former smokers.94,132  
E-cigarettes have a relative advantage over regular cigarettes, the product they 
supersede. Compared to regular cigarettes, e-cigarettes are (or are perceived to be) cheaper, 
cleaner, healthier, and more modern.94 E-cigarettes have social cachet, while regular 
cigarettes and those who use them are stigmatized.127,128,149,191 
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E-cigarettes demonstrate compatibility with the needs of their users. Although most 
smokers want to quit, they are addicted to nicotine and few quit successfully.173 Nicotine-
replacement therapies (NRTs), including products like the patch or gum and pharmacologic 
therapies like varenicline, are unpopular,192 perhaps because they deliver nicotine slowly and 
are not compatible with smokers’ needs. Unlike e-cigarettes, these other NRTs do not mimic 
the feel of holding a cigarette, drawing on it, and inhaling the smoke or the social experience 
of smoking with friends.49 E-cigarettes can be sufficiently compatible that some former 
smokers even say that their identity as a smoker has been replaced by a new identity as an e-
cigarette user or “vaper.”49 
E-cigarettes exhibit trialability. Naïve users can purchase a disposable e-cigarette at a 
gas station for less than ten dollars. In the United Kingdom, some point-of-sale displays 
allow consumers to sample e-cigarettes.193 Half of smokers have now tried e-cigarettes.137 
Because smokers gather together with other smokers in social and family groups,97,98 
smokers likely know e-cigarette users who can let them try a puff. Interested individuals do 
not have to make a long-term investment to see if they enjoy and want to adopt this 
innovation.  
Use of e-cigarettes is public, so they have a high degree of observability. E-cigarettes 
are widely advertised on television, promoted by celebrities, and discussed in the 
media.20,123,149,168 They are available at convenience stores and other frequently visited 
outlets. The blue glowing tips of Blu e-cigarettes, the most popular U.S. brand,194 are clearly 
visible. Each time that e-cigarettes are observed represents a new opportunity for discussion 
and trial. 
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E-cigarettes exhibit varying degrees of the final aspect of an innovation, complexity. 
Disposable models are simple to operate. However, non-disposable e-cigarettes have many 
components (i.e., battery, heating element, and cartridge) that can malfunction43 or do not 
work in combination.50 In addition, some users report experiencing initial frustration as they 
learn to inhale the e-cigarette vapor in a way that allows them to obtain the desired dose of 
nicotine.50 
The more of these five aspects of an innovation a product has and the more desirable 
those qualities are, the faster users will adopt it.93 That e-cigarettes embody the main features 
of an innovation could help account for the dramatic increase in prevalence of their use. In 
essence, the main audience for the product (i.e., current and former smokers) may see e-
cigarettes as an innovative replacement or addition to cigarettes; e-cigarettes, compared to 
regular cigarettes, are essentially “the same—but better.” The marketing tagline for NJOY, 
the second most popular e-cigarette brand in the United States,194 captures this idea: “You 
know the most amazing thing about this cigarette? It isn’t one.”  
Given that many e-cigarette users also continue to smoke, even if it is a reduced 
amount,94 e-cigarettes currently on the market are probably not good enough to render 
cigarettes obsolete. The high rates of dual use suggest that some aspect of the innovation 
does not meet smokers’ needs, perhaps the strength and consistency of nicotine delivery. 
Some users say that e-cigarettes do not satisfy their cravings.44 Some do not like their flavor 
or find them too expensive.43 A disposable e-cigarette can cost more than a pack of 
cigarettes. Although refills of e-juice are inexpensive, refillable e-cigarettes require an initial 
investment of at least $20 and up to $90 for a starter kit.195,196 
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A small proportion of e-cigarette users (5% in 2013)137 are not current or former 
smokers. For these users, e-cigarettes are not a replacement or complement to a product they 
are using. However, this group of users may be people who were highly susceptible to 
smoking, but simply started using e-cigarettes before they could begin smoking. Thus e-
cigarettes could be an attractive alternative (one with relative advantage, trialability, etc.) to a 
product they intended to try.  
Relationship of Dissertation Findings to Diffusion of Innovation 
Chapter 3 focused on the first phase of the diffusion process, knowledge. We found 
that 86% of U.S. adults in 2013 were aware of e-cigarettes, up from 16% in 2009.58 “Early 
knowers,” according to Rogers’ model, tend to have higher education, higher social status, 
more social participation, and greater exposure to mass media and interpersonal channels of 
information than do “late knowers.”93 Although overall rates of awareness are too high to 
consider those who were aware of e-cigarettes to be early knowers, our results were still 
consistent with this general pattern. Specifically, we found that adults with at least a college 
education were more likely to have heard of e-cigarettes than those with less than a high 
school education. Non-Hispanic Whites, a demographic group that tends to have relatively 
high socioeconomic status,197 or what Rogers might term “social status,” had greater 
awareness than other races and ethnicities. Awareness also was negatively associated with 
age, and younger adults were more likely to hear about e-cigarettes online than older adults. 
Younger adults may be earlier knowers because they participate more in social media,100-102 a 
channel that encompasses both mass media and interpersonal communication. Finally, 
current and former smokers, who had the highest rates of awareness, were more likely to hear 
about e-cigarettes from users than were never smokers. This finding suggests that smokers’ 
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homophily with other smokers98 presents an opportunity for learning about e-cigarettes 
through social participation and interpersonal channels, precisely as Rogers’ DOI model 
described.  
Chapter 4 focused on the persuasion stage by describing smokers’ perceptions of the 
risks of health harms from using e-cigarettes and other novel and traditional tobacco 
products. The persuasion stage is marked by the development of favorable and unfavorable 
attitudes. We found that smokers consistently rated e-cigarettes as less likely to cause lung 
cancer, oral cancer, and heart disease compared to regular cigarettes and other tobacco 
products (OTPs), namely smokeless tobacco, snus, and dissolvable tobacco. One contributing 
factor to the rise in popularity of e-cigarettes, which has not been matched by the alternative 
OTPs, could be that smokers view e-cigarettes as not only healthier than regular cigarettes 
(i.e., relative advantage), but also more similar in style and use compared to regular cigarettes 
(i.e., compatibility) than the alternative OTPs. Relative advantage and compatibility are 
particularly important for shaping attitudes during the persuasion change.93 
Chapter 5 tested hypotheses about the persuasion stage. Advertising not only spreads 
information during the knowledge stage (as evidenced by the first chapter), but also 
contributes to attitude formation during the persuasion stage. We found that, for smokers 
who had never tried e-cigarettes, ads emphasizing the relative advantages of e-cigarettes over 
cigarettes (e.g., healthier, cost less, helpful to quit smoking) created more interest than ads 
without comparisons, but ads emphasizing compatibility (e.g., feels the same as smoking) did 
not. Both relative advantage and compatibility are positive aspects of an innovation that 
promote its uptake. However, in this instance, the product that the innovation aims to unseat 
does not have entirely positive connotations. Smoking is a stigmatized activity.127,128,191 Even 
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smokers recognize that regular cigarettes are bad for their health,172 and most want to quit.173 
Thus it is not surprising that the innovation was most attractive when framed as different 
from the original.  
Although both focused on the persuasion stage, Chapters 4 and 5 have implications 
for the decision and implementation stages. The degree to which smokers view e-cigarettes 
as healthier than other tobacco and nicotine options and find messages about their positive 
attributes appealing could influence their decisions about uptake and the likelihood that they 
use the product.  
 
Strengths and Limitations  
Taken as a whole, these three papers tackle a breadth of research questions and 
populations of interest, from purely descriptive to experimental and from all U.S. adults to a 
specific group (i.e., smokers susceptible to e-cigarette use). All three studies benefited from a 
large national sample. Although the parent study used a combination of probability and 
convenience sampling strategies, the large probability sample and use of quota sampling 
techniques helped us match the convenience sample to the probability sample as closely as 
possible. To enable more accurate population estimates, I also weighted the data for the 
analysis in the first two chapters. I did not weight the data during the analysis of the third 
chapter because this was a randomized experiment and not meant to generalize to a 
population. These projects also benefited from their recency; the landscape of e-cigarette use 
and research is changing rapidly, and there is little 2013 data that has yet appeared in the 
literature.  
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An additional strength of the third study is its novelty. To my knowledge, there are no 
published articles using an experimental approach to explore reactions to e-cigarette 
advertising. The stimuli I used were basic print ads; that I found any differences based on 
these minimal stimuli suggests that more sophisticated ads could produce more robust 
effects. A possible critique of the study is that I included an ad that is not realistic because it 
explicitly promoted e-cigarettes as a cessation tool even though a court decision prohibits 
advertisers from making this claim unless they want the product to be regulated as a drug or 
device. However, I felt it appropriate to include this claim because advertisers frequently 
skirt this ruling by using affiliate marketing and other indirect promotional strategies.135,151  
In addition to the specific limitations that the individual manuscripts discussed, 
several limitations cut across the papers. First, e-cigarettes are part of a class of products 
called electronic nicotine delivery systems or personalized vaporizers. This survey included 
only “traditional” e-cigarettes modeled after regular cigarettes rather than encompassing this 
broader class. Prior to answering any questions about e-cigarettes, the survey introduced e-
cigarettes as follows: “An e-cigarette looks like a regular cigarette, but it runs on a battery 
and produces vapor instead of smoke. There are many types of e-cigarettes. Some common 
brands are Smoking Everywhere, NJOY, Blu, and Vapor King. Below are some pictures of e-
cigarettes.” The pictures that accompanied the text (Figure 6.1) showed e-cigarettes with the 
same shape and coloring as regular cigarettes. To be inclusive of other styles, the 
introductory statement might have said that e-cigarettes have multiple names (e.g., “vape 
pen”) and can, but do not always, look like regular cigarettes. The picture might have 
included examples of alternative types of e-cigarettes that do not look like regular cigarettes 
(Figure 6.2).  
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These research papers relied on cross-sectional data with no behavioral outcomes. 
Thus I cannot conclude that information sources, risk perceptions, or ad exposure cause 
changes in patterns of e-cigarette use. To prove such effects, we would need longitudinal 
studies with assessments at baseline and follow-up. This deficit is common across the e-
cigarette literature; few studies track the same group of participants over time using 
behavioral outcomes.  
Finally, although these projects used a diffusion of innovation framework, they did 
not explicitly test this model. For example, I did not use existing measures198 or develop 
measures to assess whether participants viewed e-cigarettes as innovative. Thus I cannot 
conclude that diffusion of innovation is the driver of our results, although I suspect it is. 
 
Future Directions 
I am interested in pursuing two lines of research on e-cigarettes that follow from my 
dissertation and similarly focus on the DOI framework. The first will track e-cigarettes 
through the remaining stages in the innovation adoption process: decision (the individual 
undertakes behaviors that lead to a choice about using e-cigarettes), implementation (the 
individual begins using e-cigarettes), and confirmation (the individual chooses to continue or 
stop using e-cigarettes). To understand decisions, I will examine users’ reasons for trying e-
cigarettes based on additional data I collected through the TCME survey. I asked e-cigarette 
users to endorse all of the reasons and then the main reason they tried e-cigarettes. The 
possible response options included, among others: “e-cigarettes come in flavors I like,” “they 
might be less harmful to people around me than regular cigarettes,” “e-cigarettes don’t smell 
bad,” “they help me deal with cravings to smoke,” and “I was curious about e-cigarettes.” I 
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also asked TCME survey participants who had tried but no longer used e-cigarettes to 
endorse all of the reasons and the main reason they stopped using e-cigarettes, i.e., the choice 
that occurs during the confirmation stage. The possible response options included: “I didn’t 
like how they tasted,” “E-cigarettes are poor quality, defective, or break easily,” “I didn’t like 
the side effects of using them,” and “I was just experimenting with e-cigarettes.” By 
analyzing these data and exploring demographic correlates, I can understand how different 
individuals move through the final stages of the DOI process from decision to confirmation.  
In an additional line of research, I want to use the DOI framework to understand the 
innovation adoption process of other, similar products. E-cigarettes are part of an ever-
expanding class of electronic nicotine delivery products. Some of these products (e.g., NJoy 
e-cigarettes) try to mimic the exact appearance of regular cigarettes. Other, newer products 
distinguish themselves with different colors (e.g., Blu e-cigarettes), shapes (e.g., tank 
models), or names (e.g., “e-hookah” or “vape pen”).199 I am interested in tracking these 
newer products, particularly ones that use a different name but operate like “traditional” e-
cigarettes, with the DOI framework as well. Does knowledge spread through the same 
channels at the same rate? Do beliefs about the health risks vary by whether the product 
includes the word “cigarette” in its name or how much the product looks like a cigarette? Do 
smokers still respond positively to messages about the relative advantage of e-cigarettes over 
cigarettes when the e-cigarette no longer resembles a cigarette or goes by that name? 
Answering these and other research questions will help clarify the applicability of the DOI 
model to a larger range of novel nicotine products, not just traditional e-cigarettes.  
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Conclusion 
The current public health value of e-cigarettes is largely unknown: safety information 
is inconsistent, data on cessation are not conclusive, and no longitudinal research yet 
establishes whether e-cigarettes serve as a gateway to other tobacco use. This dissertation 
explores exposure to information, beliefs, and responses to messages about “traditional” e-
cigarettes, but ultimately, innovations like e-cigarettes are not static. Rather, as they diffuse, 
adopters change them to fit their needs, a process that Rogers describes as re-invention.93 E-
cigarette users and manufacturers have already changed the product, and the entry of 
multinational tobacco companies into the e-cigarette market may hasten further change.25 As 
described by the DOI model, greater re-invention leads to faster and more sustainable 
adoption. If this prediction holds true, e-cigarette use will likely continue to increase in 
tandem with the product’s evolution to fit the changing needs of the user. Simply put, e-
cigarettes are not going away any time soon. Research on e-cigarettes will need to keep pace 
with the continuing evolution and diffusion of this innovation. 
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Figure 6.1. Pictures of e-cigarettes included in the TCME survey. 
 
 
 
 
 
 
 
 
 
Figure 6.2. Alternative types of electronic nicotine delivery products: e-hookah and e-
cigarette tank model. 
 
 
 
 
 
 
  
1st 
Author 
(year) 
Brief Study 
Description 
Rates of 
Awareness 
Rates and 
Amount of Use 
Reactions to Own Use 
(Users Only) 
Beliefs about and  
Reasons for Use  
(Users and Non-Users) 
Adkison 
(2013)61 
Survey of 
current and 
former 
smokers 
(n=5,939). 
47% had heard 
of ENDS.  
Higher among: 
US and UK (vs. 
Canada or 
Australia), 
young, higher 
educ, higher 
income, male, 
white. Heavy 
smokers had 
greatest 
awareness. Long 
term quitters had 
lowest.  
Ever use: 8% had 
ever tried ENDS. 
Higher among: US 
and UK, females, 
younger, higher 
income, perceived 
ENDS less 
harmful than cigs. 
Highest use 
among non-daily 
smokers and 
lowest among 
long-term quitters. 
Use not associated 
with quit 
intentions. 
Current use: 3% 
were current users.  
Highest use 
among daily heavy 
smokers and non-
daily smokers.  
 Health: 70% of 
respondents aware of 
ENDS believed they 
were less harmful than 
cigs. Varied by country. 
Of users, 80% used 
ENDS in order to reduce 
harm. 
Quit: 85% used ENDS 
to help them quit 
smoking and 75% to 
help them reduce 
smoking. 
Restrict: 70% used 
ENDS to get nicotine in 
smoke-free places. 
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 Barbeau 
(2013)49 
Focus groups 
with ENDS 
users (n=11). 
- Dual use: 1 of 11 
(9%) was a current 
smoker. 
Quit: ENDS helped users quit 
smoking, but not necessarily quit 
using nicotine. Had more 
success quitting with ENDS than 
other NRTs. 
Satisf: Enjoyed the flavors and 
variety of devices.  
Similar: ENDS use mimicked 
the feel of smoking cigs. Had 
same daily routine with ENDS 
as with cigs. Similarity of ENDS 
to cigs made it easier to switch 
from cigs to ENDS.  
Withdraw: ENDS alleviated 
withdrawal symptoms. 
Health: Believed ENDS 
were a safer form of 
nicotine delivery. 
Quit: Believed ENDS were 
better quit aids than other 
NRTs. 
 
Bullen 
(2010)53 
Randomized, 
repeated 
measures trial 
of 0 mg 
nicotine 
ENDS, 16 mg 
nicotine 
ENDS, cigs, 
and Nicorette 
inhalators 
(n=40). 
- - Health: Experienced few adverse 
events with ENDS use. Most 
common were mouth/throat 
irritation (38%), nausea (29%), 
vertigo (21%), headache (18%). 
Satisf: 16 mg nicotine ENDS 
was moderately satisfying and 
more pleasant than inhalator.  
Similar: Nicotine ENDS 
considered best alternative to 
cigs. 
Withdraw: ENDS with nicotine 
were better at reducing desire to 
smoke than ENDS without 
nicotine. 
Quit: Believed that 16 mg 
nicotine ENDS would be 
better than for own or 
friends’ quit attempts than 0 
mg nicotine ENDS or 
inhalator. 
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 Caponnetto 
(2011)86 
Case reports 
of smokers 
(n=2). 
- Participant 1 no 
longer used ENDS 
after quitting cigs. 
Participant 2 
continued using 
ENDS after quitting. 
Health: Dry cough for 
Participant 2. 
Quit: Both participants quit 
smoking after a few weeks or 
months of ENDS use. Both had 
previously failed to quit using 
other NRTs. 
- 
Caponnetto 
(2011)80 
Case reports 
of smokers 
(n=3). 
- 2 of 3 participants 
continued using 
ENDS after quitting 
smoking. 
Health: Dry cough for 
Participant 2. Participant 3 
reported improved energy and 
no exacerbations of chronic lung 
disease. 
Quit: All 3 quit smoking after 
previously failing to quit using 
other NRTs. 
Quit: All 3 began using 
ENDS to help quit smoking 
and believed they would 
not have been able to quit 
without ENDS. 
Caponnetto 
(2013)76 
12-month 
prospective 
trial of 
ENDS use 
among 
smokers 
(n=14). 
- Dual use: At week 
52, some 
participants who 
reduced smoking 
were still using 
ENDS (% not 
reported). 
Amount: Mean of 1 
ENDS cartridge (SD 
1) used per day over 
the course of the 
study. 
Health: No serious adverse 
events. Infrequent reports of dry 
cough, headache, nausea at early 
study visits. No change in 
symptoms of schizophrenia.  
Quit: At week 52, 14% quit 
smoking and another 50% 
reduced number of daily cigs by 
at least half. 
Withdraw: Participants did not 
experience withdrawal 
symptoms. 
- 
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 Caponnetto 
(2013)77 
12-month 
randomized 
trial 
comparing 
use of 
nicotine 
ENDS to 
non-nicotine 
ENDS 
(n=300). 
- Dual use: At week 
52, some participants 
who reduced 
smoking were still 
using ENDS (% not 
reported). 
Amount: Median of 
2 cartridges per day 
at early visits (weeks 
2-10), and 0 per day 
at week 24 and week 
52 visits.  
Health: No serious adverse 
events. 20% reported shortness 
of breath at baseline, but 
dropped to 4% by week 2. 
Similar patterns for cough, dry 
mouth, throat irritation and 
headache. 
Quit: At week 52, in the nicotine 
ENDS group, 13% quit and 
another 10% reduced cigs by at 
least half. 4% of the non-nicotine 
ENDS group quit and 12% 
reduced cigs by at least half. No 
statistical difference between 
groups. 
Satisf: Low satisfaction, but 
higher ratings of “would 
recommend to friend.”  
Withdraw: Few withdrawal 
symptoms reported. At week 2, 
7% reported hunger, 4% 
insomnia, 4% irritability, 3% 
anxiety, and 2% depression. 
- 
Chen 
(2013)82 
Description 
of 47 ENDS 
adverse 
event 
reports. 
- - Health: 17% of reports were 
serious adverse events (e.g., 
pneumonia, burns, seizure). 
Other health effects were minor 
(e.g., headache, cough, nausea). 
- 
Cho 
(2011)63 
Survey 
(n=4,341). 
10% had heard of 
ENDS. Most 
common sources 
were the Internet 
(46%) and friends 
(28%). 
Ever use: <1% 
overall had tried 
ENDS. Higher 
among males, ever 
smoked cigs.  
- - 
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 Choi 
(2012)89 
Focus group 
of tobacco-
users and 
non-users 
(n=66). 
- - - Gateway: Believed that 
ENDS could bring people 
closer to smoking cigs. 
Health: Disagreement and 
uncertainty about health 
effects of ENDS.  
Quit: Disagreement about 
whether ENDS help 
smokers quit. Anecdotes 
about others’ successfully 
quitting. 
Restrict: Believed that 
ENDS could be used 
anywhere and helped 
tobacco companies bypass 
smoking bans. 
Similar: Believed smokers 
will only use ENDS if 
mimic feel of cigs. 
Different social experience 
with using ENDS than with 
smoking cigs. 
Withdraw: Believed that 
people might become 
addicted to ENDS. 
 
1
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 Choi 
(2013)65 
Survey 
(n=2,624). 
70% had heard of 
ENDS. Higher 
among: males, 
higher educ, 
current and former 
smokers, at least 1 
close friend who 
smokes. 
Ever use: 7% had 
ever used ENDS. Of 
those aware of 
ENDS, higher use 
among: younger, 
male, current or 
former smoker, at 
least 1 close friend 
who smokes, believe 
ENDS less harmful, 
believe ENDS can 
help people quit 
smoking.  
Current use: 1% had 
used in past 30 days.  
- Health: 53% believed 
ENDS less harmful than 
cigs. 
Quit: 45% believed ENDS 
can help smokers quit. 
Withdraw: 26% believed 
ENDS less addictive than 
cigs. 
Dawkins 
(2012)88 
Randomized 
trial of 18 
mg nicotine 
ENDS, 0 mg 
nicotine 
ENDS, or 
just holding 
ENDS 
(n=86). 
- - Withdraw: Desire to smoke 
declined for both 18 mg and 0 
mg ENDS versus just holding an 
ENDS. Some reductions in 
withdrawal symptoms (e.g., 
anxiety, poor concentration). 
Experiences varied by gender. 
- 
Dawkins 
(2013)87 
Randomized 
trial of 0 mg 
nicotine 
ENDS and 
18 mg 
nicotine 
ENDS 
(n=20). 
- - Withdraw: Desire to smoke and 
withdrawal symptoms were 
lower with 18 mg nicotine 
ENDS than 0 mg nicotine 
ENDS. 
- 
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 Dawkins 
(2013)42 
Survey of 
ENDS users 
(n=1,347). 
First heard about 
ENDS through the 
Internet (41%), 
personal contacts 
(35%), other 
media (10%), or 
saw them being 
used (8%). 
Dual use: 16% were 
current smokers.  
Amount: Mean 316 
days of use and 
maximum of 236 
puffs per day and 3 
mL of e-liquid 
 
Health: 72% reported better 
breathing. 70% said improved 
cough. Most common side 
effects were throat (37%) and 
mouth (23%) irritation.  
Quit: 74% had not smoked for at 
least several weeks since began 
using ENDS. 89% said ENDS 
helped them quit smoking and 
94% said ENDS helped them cut 
down on smoking.  
Restrict: 36% said they 
frequently used ENDS in places 
where smoking was banned. 
Satisf: High overall satisfaction 
levels. 3% did not like taste. 
Similar: 56% said used ENDS 
“in similar manner” to cigs. 68% 
said ENDS as satisfying as cigs. 
Withdraw: 91% said using 
ENDS substantially decreased 
craving for cigs, and 70% said 
they do not have the urge to 
smoke cigs as much. 56% get 
“definite nicotine hit” from 
ENDS.  
Cost: 3% said that they 
started using ENDS because 
they were cheaper than 
smoking. 
Health: 6% said they started 
using ENDS for health 
reasons.  
Quit: 76% said they started 
using as an alternative to 
smoking.  
Restrict: 3% said they 
started using ENDS to 
avoid smoking restrictions.  
Similar: 17% liked that 
ENDS look and feel like 
cigs. 
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 Dockrell 
(2013)62 
Survey 
(n=12,597 in 
2010; 
n=12,432 in 
2012). 
Awareness among 
smokers increased 
from 62% in 2010 
to 79% in 2012. 
38% of never-
smokers and 47% 
of former smokers 
had heard of 
ENDS in 2012. 
Ever use: In 2010, 
8% of smokers had 
ever used ENDS 
(reported for 
smokers only). 
In 2012, 22% of 
current smokers, 4% 
of former smokers, 
and <1% of never 
smokers (overall % 
not reported). Higher 
use among younger 
respondents.  
Current use in 2012: 
3% of daily smokers, 
1% of former 
smokers <1% of 
never smokers 
(overall % not 
reported). 
Dual use: 3% of 
daily smokers in 
2010 and 7% in 2012 
were current ENDS 
users. 
- - 
 
1
1
3
 
 Dockrell 
(2013)62 
Survey of 
smokers 
(n=1,380). 
- Ever use: 35% had 
ever used ENDS. 
- Cost: 53% believed might 
be too expensive. 
Health: 39% believed might 
good for own health and 
40% for health of others. 
21% believed might not be 
safe enough. 71% believed 
ENDS safer than cigs. 
Quit: 55% believed ENDS 
might help to cut back on 
and 51% to help quit 
smoking. 35% of users first 
tried them to help quit 
smoking and 31% to cut 
down on smoking without 
quitting.  
Restrict: 43% of users first 
tried ENDS so they could 
use them where smoking 
not allowed. 50% believed 
ENDS might help with 
cravings where smoking is 
banned.  
Satisf: 17% believed that 
they might taste pleasant 
and 33% believed might 
taste unpleasant.  
Similar: 35% did not like 
that ENDS might be 
mistaken for cigs. 17% 
liked that ENDS might not 
resemble a cigarette. 
Withdraw: 60% believed 
ENDS might satisfy desire 
to smoke, and 39% believed 
they might not. 
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Eissenberg 
(2010)54 
Trial of 2 
brands of 16 
mg nicotine 
ENDS, cigs, 
just holding 
cigs (n=16). 
- - Withdraw: One ENDS brand 
decreased craving at 1 time 
point. No other effects of either 
ENDS brand at any other time 
point. 
- 
Etter 
(2010)43 
Survey of 
current and 
former 
ENDS users 
(n=81). 
- Amount: 89% were 
daily users. Median 
100 days of use and 
175 puffs per day.  
Cost: Mixed experiences of 
ENDS cost relative to cigs. 
Health: Most frequently listed 
positive effects: better breathing, 
less cough, and overall health 
improvement. Most frequently 
listed negative effects: dry 
mouth or throat, vertigo, 
headache, and nausea. 
Quit: Frequently listed that 
ENDS helped to quit smoking 
(79% said helped “a lot”). Some 
previously failed to quit using 
other NRTs.  
Satisf: Multiple comments that 
liked taste and smell and found 
pleasurable to use. Some disliked 
taste or had technical or quality 
problems. 
Similar: Some stopped using 
ENDS because did not taste like 
cigs. 
Withdraw: Multiple comments 
that using ENDS reduced 
cravings. 
Cost: Reasons for use 
included lower cost of 
ENDS relative to cigs.  
Health: Reasons for use 
included that ENDS are 
healthier than cigs. Some 
users concerned about 
potential toxicity.  
Quit: Many said they used 
ENDS in order to quit 
smoking. 
Restrict: Reasons for use 
included that they can use 
ENDS in smoke-free 
places. 
Satisf: Reasons for use 
included the pleasure of the 
experience. 
Similar: Similarity of 
ENDS to cigs (inhalation, 
gestures/actions) perceived 
as a benefit. 
Withdraw: Reasons for use 
included to get nicotine and 
to relieve cravings. 
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Etter 
(2011)44 
Survey 
(n=3587). 
- Ever use: 85% had 
ever used ENDS. 
Daily users (vs. 
never users) more 
likely to be men, 
former smokers, and 
have past use of 
some NRTs. 
Dual use: 22% of 
daily ENDS users 
were current 
smokers. 65% said 
they had ever used 
ENDS and tobacco 
on the same day.  
Amount: 84% were 
current ENDS users 
(81% daily and 3% 
occasional). Among 
daily ENDS users, 
median 91 days of 
use and 120 puffs 
per day.  
 
Health: 22% said burned throat; 
26% said caused dry mouth or 
throat. 
Quit: 92% of current smokers 
said ENDS helped reduce 
smoking. 96% of former 
smokers said ENDS helped them 
quit. Of those who stopped using 
ENDS, 25% said they relapsed 
to smoking. 
Restrict: 71% used at work and 
43% in restaurants/bars. 
Satisf: High satisfaction overall. 
91% liked taste, feel of 
inhalation. 94% would 
recommend to a friend. Multiple 
concerns about product quality 
(e.g., 37% said batteries run out 
too quickly and 18% said e-
liquid leaked). 35% of those who 
had stopped using ENDS did so 
because of poor quality. 
Withdraw: Of those who used 
ENDS during quit attempt, 90% 
said reduced cravings, 83% 
reduced irritability, 81% reduced 
anxiety, and 78% reduced 
restlessness. 10% still feel urge 
to smoke when using ENDS. 
89% found it easy to abstain 
from smoking when using 
ENDS. 33% of those who had 
stopped using ENDS did so 
because ENDS did not reduce 
cravings. 
Cost: 57% used because 
they believed ENDS were 
cheaper than cigs. 
Health: 84% used because 
they believed ENDS were 
less toxic than cigs. 6% 
feared ENDS might be 
toxic. 
Quit: 77% used to help quit 
smoking or avoid relapse. 
Restrict: 39% used to 
handle smoke-free 
situations. 
Withdraw: 8% were afraid 
of becoming addicted to 
ENDS. 79% of former 
smokers feared they would 
relapse if do not use ENDS. 
79% use ENDS to deal with 
cravings and 67% to deal 
with nicotine withdrawal. 
4% believed they were 
addicted to ENDS. 
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Etter 
(2011)45 
Survey with 
saliva 
collection 
from ENDS 
users (n=31). 
- Dual use: 1 
participant (3%) 
described as 
occasional smoker. 
Amount: 97% were 
daily users. Median 
94 days of use and 
200 puffs per day.  
- - 
Farsalinos 
(2013)81 
Case study 
of 1 former 
smoker. 
- Amount: Used 
ENDS daily. 
Health: Alleviated previously 
elevated white blood cell count 
(neutrophilia). 
Quit: Quit smoking cigs within 
10 days. 2 previous failed 
attempts. 
 
Farsalinos 
(2013)55 
Comparison 
of smoking 
topography 
between 
experienced 
ENDS users 
using ENDS 
(n=45) and 
ENDS naïve 
smokers 
(n=35) using 
both ENDS 
and cigs. 
- Amount: ENDS 
users were all daily 
users and former 
smokers. Had used 
ENDS mean of 7 
months and vaped 5 
mL per day. 
Observed puff 
duration longer for 
ENDS users than 
other conditions 
(smokers using cigs 
or smokers using 
ENDS). 
- - 
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Foulds 
(2011)46 
 
Survey of 
experienced 
ENDS users 
(n=104). 
- Dual use: 12% 
currently smoked 
cigs or other 
tobacco.  
Amount: 89% used 
ENDS ≥20 of past 
28 days. Mean 13 
months of use (SD 9) 
and median 20 
instances of use of 
ENDS per day.  
Quit: 99% said ENDS helped 
them successfully quit smoking. 
65% previously tried to quit 
using NRTs. 
Restrict: 90% were able to use 
where smoking was banned. 
Similar: 35% said they use 
ENDS the same amount or more 
frequently than cigs. 80% 
preferred taste of ENDS to cigs. 
Withdraw: 93% were extremely 
confident they could abstain 
from tobacco while using ENDS. 
Health: 98% believed 
ENDS less harmful to their 
own health than cigs. 80% 
believed ENDS less 
harmful to others than cigs. 
Quit: 73% started using 
ENDS to help quit tobacco. 
Restrict: 64% used because 
they could do so where 
smoking is banned. 
Withdraw: 58% believed 
they get the same or more 
nicotine with ENDS. 
Goniewicz 
(2012)64 
Survey 
(n=13,787). 
86% had heard of 
ENDS. 
Ever use: 21%. 
Higher among ever 
smokers, current 
smokers, males, 
urban areas, and 
those who had a 
smoking parent or 
partner.  
Current use: 7% used 
in the past 30 days. 
Higher among 
younger, male, 
urban, current 
smokers, and those 
who had a smoking 
parent or partner.  
Dual use: 15% of 
current smokers had 
used ENDS in past 
30 days.  
- Health: 55% believed that 
ENDS were safer than cigs. 
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Goniewicz 
(2013)47 
Survey of 
ENDS users 
(n=179). 
- Dual use: 34% of 
ENDS users were 
current smokers.  
Amount: 98% were 
daily users. 54% had 
used ≥1 month. 33% 
used ≤15 times, 27% 
16-25 times, and 
40% used > 25 times 
per day.  
 
Gateway: 20% of those who said 
they were non-smokers when 
began using ENDS became 
smokers. 
Health: Most frequent side 
effects of ENDS use were cough 
(27%), phlegm production 
(25%), and headaches (21%).  
Quit: 64% who smoked when 
they began using ENDS had quit 
smoking. 
Similar: 32% found the 
experience of using ENDS less 
satisfying, 32% equally 
satisfying, and 36% more 
satisfying than smoking. 
 
Cost: 14% tried ENDS for 
“other” reasons, which 
included cost. 
Health: 41% first tried 
ENDS as a safer alternative 
to cigs. 15% believed 
ENDS were absolutely safe, 
and 82% believed that 
ENDS were not absolutely 
safe but safer than cigs. 
Quit: 41% first tried ENDS 
to quit smoking. 
Restrict: 14% tried ENDS 
for “other” reasons, which 
included being able to use 
in smoke-free places. 
Withdraw: 33% believed 
ENDS were as addictive as 
cigs; 60% believed less 
addictive, 7% not addictive 
at all. 54% believed they 
were addicted to ENDS. 
Hua 
(2013)22 
Visual 
analysis of 
YouTube 
videos of 
individuals 
using ENDS 
and smoking 
cigarettes 
(n=73). 
- Amount: Puff 
duration for ENDS 
use was longer than 
puff duration for 
cigarette smoking. 
- - 
 
 
 
 
1
1
9
 
  
Hua 
(2013)83 
Analysis of 
reports of 
health 
effects from 
ENDS use 
(n=543 
posts) 
- - Health: 405 symptoms (78 
positive, 326 negative, 1 neutral) 
reported. Most common negative 
symptoms were in the mouth and 
throat and in the respiratory, 
neurological, sensory, and 
digestive systems. 
- 
King 
(2013)60 
Surveys in 
2010 
(n=6,689) 
and 2011 
(n=4,050). 
39-41% had heard 
of ENDS in 2010. 
58% had heard of 
ENDS in 2011. 
Higher among 
current smokers. 
Lower among ≥65 
years, African 
Americans, low 
educ. 
Ever use: In 2010, 2-
3% had ever tried 
ENDS. Higher 
among current 
smokers. In 2011, 
6% had ever tried 
ENDS. Higher 
among current 
smokers. 
- - 
Kralikova 
(2012)51 
Brief 
structured 
interviews of 
smokers 
(n=973). 
86% had heard of 
ENDS. 
Ever use: 26% had 
ever tried ENDS. 
Dual use: 7% used 
ENDS regularly. 
Cost: 13% of those who stopped 
using ENDS found them too 
expensive. 
Satisf: 43% disappointed with 
ENDS use experience, 33% 
found as expected, and 24% 
better than expected. Of those 
who stopped using ENDS, 33% 
reported lack of satisfaction and 
32% did not like taste. 
Similar: “Other” reasons (4%) 
for stopping using ENDS 
included that ENDS did not have 
the same “natural timing” of 
cigs. 
 
 
 
 
1
2
0
 
  
Li (2013)70 Surveys of 
smokers and 
recent 
quitters in 
2011 
(n=480) and 
2012 
(n=360). 
- Ever use: 7% of 
respondents in 2011 
survey had ever 
purchased an ENDS 
(proxy for use). 
Higher among 
younger adults, 
higher income. Not 
associated with quit 
attempts. 
- Cost: 41% would switch to 
ENDS if cheaper than cigs. 
Health: 33% believed 
ENDS were safer than cigs. 
Quit: 34% believed ENDS 
could help people quit. 58% 
said they would try ENDS 
to help them quit smoking.  
McCauley 
(2012)84 
Case study 
of patient 
with lipid 
pneumonia 
(n=1). 
- Amount: Used 
ENDS for 7 months 
before diagnosis. 
Health: Developed lipid 
pneumonia from glycerin-based 
oils in ENDS vapor. Improved 
after stopping use of ENDS. 
- 
McMillen 
(2012)67 
Surveys 
(n=3,240). 
- Ever use: 2% had 
ever tried ENDS. 
Higher among 
current smokers.  
Current use: <1% of 
total sample (20% of 
those who had ever 
tried ENDS) had 
used ENDS in past 
30 days.  
- - 
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McQueen 
(2011)50 
Interviews 
with 
dedicated 
ENDS users 
(n=15). 
Most common 
sources of initial 
awareness: friends, 
ads, Internet. 
Amount: Most used 
ENDS ≤ 1 year. 
Cost: Most found ENDS less 
expensive than cigs. 
Health: Less coughing and 
breathlessness and greater ability 
to be physically active when 
using ENDS. 
Quit: Had success quitting with 
ENDS even after failed with 
other quit aids. 
Satisf: Overall very satisfied. 
ENDS sometimes required 
troubleshooting or did not work 
as expected. 
Similar: Many switched from 
ENDS that look like cigs to 
modified ENDS.  
Withdraw: Some ENDS users 
experienced fewer withdrawal 
symptoms between bouts of use 
than they did with cigs, and they 
experienced relief of cravings 
within 5 minutes after use of 
ENDS. 
Health: Users hoped that 
ENDS reduce health risks. 
Similar: Because ENDS are 
more complex than cigs, 
they believed there was a 
learning curve to ENDS 
use. Some believed ENDS 
could substitute for cigs 
because same physical 
actions of using.  
Withdraw: Believed ENDS 
could help get a “nicotine 
fix.” Believed that novice 
ENDS users could 
experience relapse 
temptation when cannot get 
ENDS to function properly. 
Monroy 
(2012)85 
Case study 
of 1 ENDS 
user. 
- Amount: Reported 
using ENDS for past 
5-6 months. 
Health: ENDS use associated 
with heart arrhythmia. Resolved 
after stopped using ENDS. 
- 
 
 
 
 
 
 
 
 
 
1
2
2
 
  
Pearson 
(2012)59 
Survey 
(n=2,649). 
40% had heard of 
ENDS. Higher 
awareness among: 
current and former 
smokers, men, 
younger 
respondents. 
Lower among 
African-
Americans. 
Ever use: 3% had 
ever used ENDS. 
Higher among 
smokers and younger 
age. For smokers, 
higher use if plan to 
quit in next 6 months 
(vs. no plans to quit). 
Not associated with 
quit attempts. 
Current use: 1% of 
sample (36% of ever 
users) had used in 
past 30 days. Higher 
among smokers and 
younger age. 
Dual use: 4% of 
current smokers had 
used ENDS in past 
30 days. 
- Health: 71% of smokers 
aware of ENDS believed 
they were less harmful than 
cigs.  
Pearson 
(2012)59 
Survey of 
smokers 
(n=3,658). 
58% had heard of 
ENDS. Higher 
among men. 
Lower among 
African-
Americans. 
Ever use: 6% of 
current smokers and 
3% of former 
smokers had ever 
used ENDS. Higher 
use among White, 
higher educ, younger 
age. Not associated 
with quit intentions 
or attempts. 
- Health: 85% of smokers 
who were aware of ENDS 
believed they were less 
harmful than cigs. 
Pepper 
(2013)66 
Survey 
(n=228). 
67% had heard of 
ENDS. Higher 
among older 
adolescents, non-
Hispanic. 
Ever use: <1% (n=2) 
had ever tried 
ENDS. Both were 
smokers. 
 
- - 
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Polosa 
(2011)75 
6-month 
prospective 
trial of 
smokers 
(n=40) using 
ENDS. 
- Dual use: At week 
24, some participants 
who reduced 
smoking were still 
using ENDS (% not 
reported). 
Amount: Mean 2 
ENDS cartridges 
used per day (SD 1, 
range 0-4). 
Health: No serious adverse 
events. Reports of dry cough 
(32%), mouth (21%) or throat 
(32%) irritation at early study 
visits. Most side effects resolved 
by week 24. 
Quit: 23% quit smoking and 
another 33% reduced number of 
daily cigs ≥50%. Rated ENDS 
highly as helpful to enable them 
to refrain from smoking. 
Satisf: Moderately high ratings 
of satisfaction. Enjoyed feeling 
of inhalation and exhalation. 
Multiple participants 
experienced problems with 
malfunctioning ENDS. 
Withdraw: Participants reported 
not experiencing withdrawal 
symptoms. 
Quit: Rated ENDS highly 
for recommending to 
friends or relatives who 
want to quit smoking. 
Popova 
(2013)68 
Survey of 
current or 
recently quit 
smokers 
(n=1,836). 
- Ever use: 20% had 
ever used ENDS. 
Higher among 
women, younger 
age, Asians, and 
unsuccessful quitters 
(vs. never tried to 
quit). Not associated 
with quit intentions. 
Current use: 8% used 
ENDS in past month. 
Higher among those 
with moderate 
education, lower 
income.  
- Quit: Greater interest in 
ENDS among smokers who 
plan to quit at any point vs. 
those who do not plan to 
quit. 
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Prochaska 
(2012)90 
Descriptive 
analysis of 
Twitter 
accounts 
(n=153). 
- - - Health: Tweets about 
ENDS included both health 
warnings and claims of 
health benefits over cigs. 
Quit: Some tweets 
described ENDS as a way 
to quit smoking. 
Regan 
(2013)58 
Surveys 
(n=10,587 in 
2009; 
n=10,328 in 
2010) 
16% in 2009 and 
32% in 2010 had 
heard of ENDS. 
Higher awareness 
in 2010 among: 
males, younger, 
non-Hispanic 
White, current 
smokers, current 
tobacco users. 
Respondents with 
low educ (less than 
high school) less 
likely to be aware 
and those with 
some college more 
likely to be aware 
compared to 
college graduates. 
Ever use: 1% in 
2009. 3% in 2010 
had tried ENDS. In 
2010, higher among: 
women, very low 
and moderate 
incomes, low educ, 
former smokers, 
current smokers. Not 
associated with quit 
attempts or 
intentions. 
Current use: In 2010, 
1% of sample (43% 
of ever users) had 
used in past month. 
Higher among: low 
educ, current 
smokers, current 
tobacco users. 
Dual use: In 2010, 
6% of current 
smokers and 7% of 
current tobacco users 
had used ENDS in 
past month. 
- Quit: Among smokers, 
ENDS users and non-users 
did not differ in quit 
intentions. 
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Richardson 
(2012)69 
Survey of 
cig and cigar 
smokers 
(n=1,310) 
- Ever use: 10% of 
cig-only smokers 
and 24% of dual cig 
and cigar smokers 
had ever tried 
ENDS.  
- Health: 83% of cigar only 
smokers, 63% of dual cig 
and cigar smokers, and 35% 
of cig-only smokers 
believed that ENDS were 
less harmful than cigs. 
Siegel 
(2011)48 
Survey of 
ENDS ever 
users 7 
months after 
initial 
purchase 
(n=216). 
- Current use: At 6 
months after 
purchase, 45% were 
not using ENDS, 
33% non-daily user, 
and 22% daily users.  
Dual use: among 
current ENDS users 
at 6-month follow-
up, 65% smoked 
cigs. 
Amount: Among 
users, 40% were 
daily users. 68% 
used ENDS ≤10 
times per day. 
Quit: 67% had reduced number 
of cigs per day. 49% quit 
smoking for some period of 
time, and 31% were smoking 
abstinent at 6-month follow-up.  
- 
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Sutfin 
(2013)71 
Survey 
(n=4,444). 
- Ever use: 5% had 
ever used ENDS. 
Higher use among: 
males, Hispanic and 
other race students, 
members of 
fraternities/sororities, 
and current and 
former smokers (vs. 
never smokers). Less 
likely among those 
who “don’t know” 
about harms of 
ENDS vs. believed 
equally harmful. Not 
associated with quit 
intentions among 
smokers. Of ENDS 
ever users, 12% were 
never, 30% were 
former, 42% were 
current smokers.  
Current use: 2% had 
used in past month. 
- Health: 23% believed 
ENDS were less harmful, 
17% as harmful, and 2% 
more harmful than cigs. 
50% said they did not 
know.  
Quit: Among smokers, 
ENDS users and non-users 
did not differ in quit 
intentions. 
Trumbo 
(2013)52 
Survey 
(n=244). 
71% had heard of 
ENDS. Higher 
among current or 
former smokers 
than never 
smokers. 
Ever use: 13% had 
ever tried ENDS. 
- Restrict: Believed that 
using ENDS in public 
places (e.g., restaurants) 
was more acceptable than 
smoking cigs in those 
places. 
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Vansickel 
(2010)56 
Trial of 16 
mg nicotine 
ENDS, 18 
mg nicotine 
ENDS, cigs, 
and “sham” 
(unlit cigs) 
(n=32). 
- - Satisf: Ratings of satisfying and 
pleasant increased at all time 
points for both ENDS. Ratings 
of “taste good” increased for 
some time points for both 
ENDS. 
Similar: Ratings of “mild as own 
brand [of cigs]” increased at 
most time points for 1 brand of 
ENDS. 
Withdraw: Both ENDS 
significantly reduced intention to 
smoke, anticipation of 
withdrawal, craving, and urge to 
smoke relative to baseline or 
sham at some time points during 
observation. 
 
Vansickel 
(2012)57 
Within-
subject 
“choice 
sessions” of 
money 
versus puffs 
of ENDS or 
cigs (n=20). 
- - Satisf: Increases in “pleasant,” 
“satisfying,” and “taste good” 
after use of ENDS. 
Similar: Increases in “harsh as 
own brand [of cigs],” “mild as 
own brand,” and “taste like own 
brand” after use of ENDS. 
Withdraw: Decreases in 
intention to smoke, anticipation 
of relief from withdrawal, and 
urge to smoke after use of 
ENDS. 
 
Vansickel 
(2013)79 
Observation 
of 5-hour 
“puff 
sessions” of 
ENDS users 
(n=8). 
- Amount: Mean 12 
months of use. 
Satisf: ENDS use increased 
ratings of pleasantness, 
satisfaction, and “taste good.” 
Withdraw: ENDS use decreased 
anxiety, restlessness, and 
intention to smoke. 
- 
1
2
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Vickerman 
(2013)74 
Survey with 
tobacco 
users who 
previously 
called state 
quitlines 
(n=2,476). 
- Ever use: 31% had 
ever tried ENDS. 
Higher among 
White, higher educ, 
live/work with other 
tobacco users. ENDS 
users less likely to 
have quit than never 
users. 
Current use: 9% used 
ENDS at time of 
survey. 
Amount: Of users, 
27% used every day 
and 73% used some 
days. 62% had used 
for <1 month. 
 Cost: 2% of ever users tried 
ENDS because cheaper than 
cigs. 
Health: 5% tried ENDS 
because they believed that 
they were less harmful than 
cigs. 
Quit: 51% tried ENDS to 
quit other tobacco, 15% to 
replace other tobacco, and 
7% to reduce other tobacco. 
Restrict: 5% tried ENDS to 
use in places where other 
tobacco was not allowed. 
Similar: 6% used because 
ENDS were a behavioral 
substitute. 
Withdraw: 5% used to deal 
with cravings, stress, or 
nerves. 
 
Note: Some % approximate due to rounding and variations in sample size. Cig = regular tobacco cigarette. ENDS = electronic 
nicotine delivery system. Mg = milligram. Ml = milliliter. Educ = education. NRT = nicotine replacement therapy (e.g., patch, 
gum, varenicline). - = not applicable. Dual use only reported if data are available on current ENDS use. Cost = the cost of ENDS. 
Gateway = use of ENDS causing smoking initiation. Health = health, safety, and side effects of ENDS. Quit = quitting and 
reducing tobacco use. Restrict = using ENDS to avoid restrictions on smoking. Satisf = satisfaction with ENDS’ taste, smell, and 
product quality. Similar = similarity of ENDS to regular cigarettes in taste, smell, or feeling of use. Withdraw = withdrawal 
symptoms, desire to smoke, and cravings. 
 
 
 
 
 
 
 
1
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